The present invention relates generally to self-retaining systems for surgical procedures, methods of manufacturing self-retaining systems for surgical procedures, and their uses.
Wound closure devices such as sutures and staples have been widely used in superficial and deep surgical procedures in humans and animals for closing wounds, repairing traumatic injuries or defects, joining tissues together [bringing severed tissues into approximation, closing an anatomical space, affixing single or multiple tissue layers together, creating anastomoses between two hollow (luminal) structures, adjoining tissues, attaching or reattaching tissues to their proper anatomical location], attaching foreign elements to tissues (affixing medical implants, devices, prostheses and other functional or supportive devices), and for repositioning tissues to new anatomical locations (repairs, tissue elevations, tissue grafting and related procedures) to name but a few examples. Sutures typically consist of a filamentous suture thread attached to a needle with a sharp point (attachment of sutures and surgical needles is described in U.S. Pat. Nos. 3,981,307, 5,084,063, 5,102,418, 5,123,911, 5,500,991, 5,722,991, 6,012,216, and 6,163,948, and U.S. Patent Application Publication No. U.S. 2004/0088003). Classically, the needle is advanced through the desired tissue on one side of the wound and then through the adjacent side of the wound to form a “loop” which is then completed by tying a knot in the suture.
Sutures materials are broadly classified as being bioabsorbable (i.e., they break down completely in the body over time), such as those composed of catgut, glycolic acid polymers and copolymers, lactic acid polymers and copolymers; or as being non-absorbable (permanent; nondegradable), such as those made of polyamide, polytetrafluoroethylene, polyether-ester, polyurethane, metal alloys, metal (e.g., stainless steel wire), polypropylene, polyethelene, silk, and cotton. Absorbable sutures have been found to be particularly useful in situations where suture removal might jeopardize the repair or where the natural healing process renders the support provided by the suture material unnecessary after wound healing has been completed; as in, for example, completing an uncomplicated skin closure. Nondegradable (non-absorbable) sutures are used in wounds where healing may be expected to be protracted or where the suture material is needed to provide physical support to the wound for long periods of time; as in, for example, deep tissue repairs, high tension wounds, many orthopedic repairs and some types of surgical anastomoses. The present invention provides for polymeric formulations, surface properties, configurations and diameters designed to increase the holding power, durability and strength of self-retaining closure systems composed of both bioabsorbable and non-absorbable polymers.
A new type of suture has been designed with barbs, or with frusto-conical retainers, for engaging tissue when the suture is pulled in a direction other than that in which it was originally deployed in the tissue. Knotless tissue-approximating devices having barbs have been previously described in, for example, U.S. Pat. No. 5,374,268, disclosing armed anchors having barb-like projections, while suture assemblies having barbed lateral members have been described in U.S. Pat. Nos. 5,584,859 and 6,264,675. One of the earlier patents describing a barbed suture is U.S. Pat. No. 3,716,058, which discloses a suture having one or more relatively rigid barbs at its opposite ends; the presence of the barbs just at the ends of the suture would limit the barbs' effectiveness. Sutures having a plurality of barbs positioned along a greater portion of the suture are described in U.S. Pat. No. 5,931,855, which discloses a unidirectional barbed suture, and U.S. Pat. No. 6,241,747, which discloses a bidirectional barbed suture. Methods and apparatus for forming barbs on sutures have been described in, for example, U.S. Pat. Nos. 6,848,152, while methods of manufacturing sutures with frusto-conical retainers have also been described in European Patent 1 075 843.
Despite their advantages over conventional sutures, current designs of barbed sutures can break, slip through tissue, incompletely deploy, not fully anchor and/or rotate in situ, leading to suboptimal clinical results and limiting their utility. In the present invention, novel tissue retainer configurations, secondary retainer structures and expanded segment suture configurations are described that increase the ability of the self-retaining sutures to anchor into their surrounding tissue, strengthen their hold, increase the amount of tension they can withstand (without breakage or slippage) and increase their clinical performance.
Sutures may be configured to more effectively distribute or resist tensions upon them when deployed in tissue.
In one aspect, a suture may include an expanded section disposed away from either end of the suture.
In another aspect, a suture may include one or more tissue retainers having an uneven or roughened surface.
In another aspect, a suture may include a continuous helical tissue retainer that is unidirectional.
In another aspect, a suture may include a continuous helical tissue retainer that is bidirectional. In the bidirectional configuration, the helix is oriented in one direction projecting “away” from the needle until the midpoint (or transition point) of the suture is reached; at this point the configuration of the helix reverses itself 180° along the remaining length of the suture thread before attaching to a second needle at the opposite end.
In another aspect, a method of manufacturing a helical self-retaining suture may include cutting a continuous helical tissue retainer in one chiral direction angled away from the suture deployment end, and a second continuous helical tissue retainer cut in the opposite chiral direction also angled away from the deployment end.
In another aspect, a method of manufacturing a bidirectional helical self-retaining suture may include cutting a continuous helical tissue retainer in one chiral direction angled away from a first suture deployment end and a second continuous helical tissue retainer cut in the opposite chiral direction also angled away from the first suture deployment end, both at a first portion of the suture that is proximal to the first suture deployment end. The method may further include cutting a continuous helical tissue retainer in one chiral direction angled away from a second suture deployment end and a second continuous helical tissue retainer cut in the opposite chiral direction also angled away from the second suture deployment end, both at a second portion of the suture that is proximal to the second suture deployment end and that is disposed away from the first portion
In yet another aspect, a suture may include tissue retainer “scales” that increase the percentage of the surface area covered by retaining elements as compared to intermittent “barb” configurations. Such tissue retainer scales may include pointed or rounded tissue penetrating edges.
In another aspect, a method of manufacturing a “scaled” self-retaining suture may include cutting a continuous helical tissue retainer in one chiral direction angled away from the suture deployment end, while a second continuous helical tissue retainer is cut in the opposite chiral direction and (also angled away from the suture deployment end).
In yet another aspect, a suture may include one or more primary tissue retainers, with at least one such primary tissue retainer that further includes one or more secondary tissue retainers. Such secondary tissue retainers may include flanges, barbs, and filaments.
In yet another aspect, the surface of the portion of the suture material that is not composed of primary tissue retainers (i.e., the “unbarbed” areas of the thread), are modified such that they further include one or more secondary tissue retainers. Such secondary tissue retainers may include flanges, barbs, and filaments.
In yet another aspect, the surface of the portion of the suture material that is not composed of primary tissue retainers (i.e., the “non-barbed” areas of the thread) and the primary tissue retainers themselves are both modified to further include one or more secondary tissue retainers. Such secondary tissue retainers may include flanges, barbs, and filaments.
In a further aspect, a method of making a self-retaining suture includes the step of cutting intersecting helical escarpments into the circumferential periphery of a suture body. Such helical escarpments may intersect due to differing pitches or opposing chirality of the helices.
In another aspect, a method of making a self retaining suture includes an expanded section of the thread such that the diameter of the expanded portion of the thread is greater than the diameter the end of the suture, or, if the suture is adapted for deployment with a needle, than the diameter of the needle.
In yet another aspect, a method of making a bidirectional self retaining suture includes an expanded section of the thread such that the diameter of the thread at a specified distance from either needle attachment site (this distance will vary depending upon the clinical indication) is greater than the diameter of the needles that are attached to it; from the point where the barbed suture thread diameter is greatest, the diameter of the thread then tapers down (the rate and length of the tapering segment will vary depending upon the clinical indication) as it approaches the needle attachment sites until the thread diameter is equal to, or smaller than, the diameter of the needles it is attached to.
The details of one or more embodiments are set forth in the description below. Other features, objects and advantages will be apparent from the description, the drawings, and the claims. In addition, the disclosures of all patents and patent applications referenced herein are incorporated by reference in their entirety.
a, 1b, and 1c are perspective views of an embodiment according to the present invention of a self-retaining suture having uneven-surfaced retainers.
d is a perspective view of a further embodiment according to the present invention of a self-retaining suture having uneven-surfaced retainers.
a and 2b are perspective views of an embodiment according to the present invention of a self-retaining suture having an expanded transition segment.
a, 3b, 3c, and 3d are perspective views of a use of an embodiment according to the present invention of a self-retaining suture having an expanded transition segment.
e is a perspective view of a use of an embodiment according to the present invention of a self-retaining suture having an expanded transition segment.
a and 4b are perspective views of embodiments according to the present invention of single helix self-retaining sutures.
c is perspective view of an embodiment according to the present invention of a double helix self-retaining suture in an unexpanded position.
d is perspective view of an embodiment according to the present invention of a double helix self-retaining suture in an expanded position.
a and 8b are perspective views of an embodiment according to the present invention of a bidirectional double helix self-retaining suture having an expanded transition segment.
a and 9b are perspective views of a further embodiment according to the present invention of a bidirectional scaled self-retaining suture having rounded retainers and an expanded transition segment.
a is a partial cut away view of a cutting device for cutting a helical retainer in a suture body according to an embodiment of the present invention.
b-14f are plan views of cutting fixtures for providing relative helical motion between a cutting device and a suture body according to embodiments of the present invention.
a-15b are side and end views of an alternative cutting device according to embodiments of the present invention.
c is a side view of an alternative cutting device according to an embodiment of the present invention.
Prior to setting forth the invention, it may be helpful to an understanding thereof to first set forth definitions of certain terms that are used hereinafter.
“Self-retaining system” refers to a self-retaining suture together with means for deploying the suture into tissue. Such deployment means include, without limitation, suture needles and other deployment devices as well as sufficiently rigid and sharp ends on the suture itself to penetrate tissue.
“Self-retaining suture” refers to a suture that does not require a knot or a suture anchor at its end in order to maintain its position into which it is deployed during a surgical procedure. These may be monofilament sutures or braided sutures, and are positioned in tissue in two stages, namely deployment and affixation, and include at least one tissue retainer.
“Tissue retainer” (or simply “retainer”) or “barb” refers to a suture element having a retainer body projecting from the suture body and a retainer end adapted to penetrate tissue. Each retainer is adapted to resist movement of the suture in a direction other than the direction in which the suture is deployed into the tissue by the surgeon, by being oriented to substantially face the deployment direction (i.e. they lie flat when pulled in the deployment direction; and open or “fan out” when pulled in a direction contrary to the deployment direction). As the tissue-penetrating end of each retainer faces or points away from the deployment direction when moving through tissue during deployment, the tissue retainers should not catch or grab tissue during this phase. Once the self-retaining suture has been deployed, a force exerted in another direction (often substantially opposite to the deployment direction) causes the retainers to be displaced from their deployment positions (i.e. resting substantially along the suture body), forces the retainer ends to open (or “fan out”) from the suture body in a manner that catches and penetrates into the surrounding tissue, and results in tissue being caught between the retainer and the suture body; thereby “anchoring” or affixing the self retaining suture in place.
“Retainer configurations” refers to configurations of tissue retainers and can include features such as size, shape, surface characteristics, and so forth. These are sometimes also referred to as “barb configurations”.
“Bidirectional suture” refers to a self-retaining suture having retainers oriented in one direction at one end and retainers oriented in the other direction at the other end. A bidirectional suture is typically armed with a needle at each end of the suture thread. Many bidirectional sutures have a transitional segment located between the two barb orientations.
“Transition segment” refers to a retainer-free (barb-free) portion of a bidirectional suture located between a first set of retainers (barbs) oriented in one direction and a second set of retainers (barbs) oriented in another direction.
“Suture thread” refers to the filamentary body component of the suture, and, for sutures requiring needle deployment, does not include the suture needle. The suture thread may be monofilamentary, or, multifilamentary.
“Monofilament suture” refers to a suture comprising a monofilamentary suture thread.
“Braided suture” refers to a suture comprising a multifilamentary suture thread. The filaments in such suture threads are typically braided, twisted, or woven together.
“Degradable (also referred to as “biodegradable” or “bioabsorbable”) suture” refers to a suture which, after introduction into a tissue is broken down and absorbed by the body. Typically, the degradation process is at least partially mediated by, or performed in, a biological system. “Degradation” refers to a chain scission process by which a polymer chain is cleaved into oligomers and monomers. Chain scission may occur through various mechanisms, including, for example, by chemical reaction (e.g., hydrolysis, oxidation/reduction, enzymatic mechanisms or a combination or these) or by a thermal or photolytic process. Polymer degradation may be characterized, for example, using gel permeation chromatography (GPC), which monitors the polymer molecular mass changes during erosion and breakdown. Degradable suture material may include polymers such as polyglycolic acid, copolymers of glycolide and lactide, copolymers of trimethylene carbonate and glycolide with diethylene glycol (e.g., MAXON™, Tyco Healthcare Group), terpolymer composed of glycolide, trimethylene carbonate, and dioxanone (e.g., BIOSYN™ [glycolide (60%), trimethylene carbonate (26%), and dioxanone (14%)], Tyco Healthcare Group), copolymers of glycolide, caprolactone, trimethylene carbonate, and lactide (e.g., CAPROSYN™, Tyco Healthcare Group). These sutures can be in either a braided multifilament form or a monofilament form. The polymers used in the present invention can be linear polymers, branched polymers or multi-axial polymers. Examples of multi-axial polymers used in sutures are described in U.S. Patent Application Publication Nos. 20020161168, 20040024169, and 20040116620. Sutures made from degradable suture material lose tensile strength as the material degrades.
“Non-degradable (also referred to as “non-absorbable”) suture” refers to a suture comprising material that is not degraded by chain scission such as chemical reaction processes (e.g., hydrolysis, oxidation/reduction, enzymatic mechanisms or a combination or these) or by a thermal or photolytic process. Non-degradable suture material includes polyamide (also known as nylon, such as nylon 6 and nylon 6.6), polyester (e.g., polyethylene terephthlate), polytetrafluoroethylene (e.g., expanded polytetrafluoroethylene), polyether-ester such as polybutester (block copolymer of butylene terephthalate and polytetra methylene ether glycol), polyurethane, metal alloys, metal (e.g., stainless steel wire), polypropylene, polyethelene, silk, and cotton. Sutures made of non-degradable suture material are suitable for applications in which the suture is meant to remain permanently or is meant to be physically removed from the body.
“Suture diameter” refers to the diameter of the body of the suture. It is to be understood that a variety of suture lengths may be used with the sutures described herein and that while the term “diameter” is often associated with a circular periphery, it is to be understood herein to indicate a cross-sectional dimension associated with a periphery of any shape. Suture sizing is based upon diameter. United States Pharmacopeia (“USP”) designation of suture size runs from 0 to 7 in the larger range and 1-0 to 11-0 in the smaller range; in the smaller range, the higher the value preceding the hyphenated zero, the smaller the suture diameter. The actual diameter of a suture will depend on the suture material, so that, by way of example, a suture of size 5-0 and made of collagen will have a diameter of 0.15 mm, while sutures having the same USP size designation but made of a synthetic absorbable material or a non-absorbable material will each have a diameter of 0.1 mm. The selection of suture size for a particular purpose depends upon factors such as the nature of the tissue to be sutured and the importance of cosmetic concerns; while smaller sutures may be more easily manipulated through tight surgical sites and are associated with less scarring, the tensile strength of a suture manufactured from a given material tends to decrease with decreasing size. It is to be understood that the sutures and methods of manufacturing sutures disclosed herein are suited to a variety of diameters, including without limitation 7, 6, 5, 4, 3, 2, 1, 0, 1-0, 2-0, 3-0, 4-0, 5-0, 6-0, 7-0, 8-0, 9-0, 10-0 and 11-0.
“Suture deployment end” refers to an end of the suture to be deployed into tissue; one or both ends of the suture may be suture deployment ends. The suture deployment end may be attached to deployment means such as a suture needle, or may be sufficiently sharp and rigid to penetrate tissue on its own.
“Armed suture” refers to a suture having a suture needle on at least one suture deployment end.
“Needle attachment” refers to the attachment of a needle to a suture requiring same for deployment into tissue, and can include methods such as crimping, swaging, using adhesives, and so forth. The point of attachment of the suture to the needle is known as the swage.
“Suture needle” refers to needles used to deploy sutures into tissue, which come in many different shapes, forms and compositions. There are two main types of needles, traumatic needles and atraumatic needles. Traumatic needles have channels or drilled ends (that is, holes or eyes) and are supplied separate from the suture thread and are threaded on site. Atraumatic needles are eyeless and are attached to the suture at the factory by swaging whereby the suture material is inserted into a channel at the blunt end of the needle which is then deformed to a final shape to hold the suture and needle together. As such, atraumatic needles do not require extra time on site for threading and the suture end at the needle attachment site is smaller than the needle body. In the traumatic needle the thread comes out of the needle's hole on both sides and often the suture rips the tissues to a certain extent as it passes through. Most modern sutures are swaged atraumatic needles. Atraumatic needles may be permanently swaged to the suture or may be designed to come off the suture with a sharp straight tug. These “pop-offs” are commonly used for interrupted sutures, where each suture is only passed once and then tied. For barbed sutures that are uninterrupted, these atraumatic needles would be ideal.
Suture needles may also be classified according to their point geometry. For example, needles may be (i) “tapered” whereby the needle body is round and tapers smoothly to a point; (ii) “cutting” whereby the needle body is triangular and has sharpened cutting edge on the inside; (iii) “reverse cutting” whereby the cutting edge is on the outside; (iv) “trocar point” or “tapercut” whereby the needle body is round and tapered, but ends in a small triangular cutting point; (v) “blunt” points for sewing friable tissues; (vi) “side cutting” or “spatula points” whereby the needle is flat on top and bottom with a cutting edge along the front to one side (these are typically used for eye surgery).
Suture needles may also be of several shapes including, (i) straight, (ii) half curved or ski, (iii) ¼ circle, (iv) ⅜ circle, (v) ½ circle, (vi) ⅝ circle, (v) and compound curve.
Suturing needles are described, for example, in U.S. Pat. Nos. 6,322,581 and 6,214,030 (Mani, Inc., Japan); and 5,464,422 (W. L. Gore, Newark, Del.); and 5,941,899; 5,425,746; 5,306,288 and 5,156,615 (US Surgical Corp., Norwalk, Conn.); and 5,312,422 (Linvatec Corp., Largo, Fla.); and 7,063,716 (Tyco Healthcare, North Haven, Conn.). Other suturing needles are described, for example, in U.S. Pat. Nos. 6,129,741; 5,897,572; 5,676,675; and 5,693,072. The sutures described herein may be deployed with a variety of needle types (including without limitation curved, straight, long, short, micro, and so forth), needle cutting surfaces (including without limitation, cutting, tapered, and so forth), and needle attachment techniques (including without limitation, drilled end, crimped, and so forth). Moreover, the sutures described herein may themselves include sufficiently rigid and sharp ends so as to dispense with the requirement for deployment needles altogether.
“Needle diameter” refers to the diameter of a suture deployment needle at the widest point of that needle. While the term “diameter” is often associated with a circular periphery, it is to be understood herein to indicate a cross-sectional dimension associated with a periphery of any shape.
“Wound closure” refers to a surgical procedure for closing of a wound. An injury, especially one in which the skin or another external or internal surface is cut, torn, pierced, or otherwise broken is known as a wound. A wound commonly occurs when the integrity of any tissue is compromised (e.g., skin breaks or burns, muscle tears, or bone fractures). A wound may be caused by an act, such as a gunshot, fall, or surgical procedure; by an infectious disease; or by an underlying medical condition. Surgical wound closure facilitates the biological event of healing by joining, or closely approximating, the edges of those wounds where the tissue has been torn, cut, or otherwise separated. Surgical wound closure directly apposes or approximates the tissue layers, which serves to minimize the volume new tissue formation required to bridge the gap between the two edges of the wound. Closure can serve both functional and aesthetic purposes. These purposes include elimination of dead space by approximating the subcutaneous tissues, minimization of scar formation by careful epidermal alignment, and avoidance of a depressed scar by precise eversion of skin edges.
“Tissue elevation procedure” refers to a surgical procedure for repositioning tissue from a lower elevation to a higher elevation (i.e. moving the tissue in a direction opposite to the direction of gravity). The retaining ligaments of the face support facial soft tissue in the normal anatomic position. However, with age, gravitational effects achieve a downward pull on this tissue and the underlying ligaments, and fat descends into the plane between the superficial and deep facial fascia, thus allowing facial tissue to sag. Face-lift procedures are designed to lift these sagging tissues, and are one example of a more general class of medical procedure known as a tissue elevation procedure. More generally, a tissue elevation procedure reverses the appearance change that results from gravitation effects over time, and other temporal effects that cause tissue to sag, such as genetic effects. It should be noted that tissue can also be repositioned without elevation; in some procedures tissues are repositioned laterally (away from the midline), medially (towards the midline) or inferiorly (lowered) in order to restore symmetry (i.e. repositioned such that the left and right sides of the body “match”).
“Medical device” or “implant” refers to any object placed in the body for the purpose of restoring physiological function, reducing/alleviating symptoms associated with disease, and/or repairing/replacing damaged or diseased organs and tissues. While normally composed of biologically compatible synthetic materials (e.g., medical-grade stainless steel, titanium and other metals: polymers such as polyurethane, silicon, PLA, PLGA and other materials) that are exogenous, some medical devices and implants include materials derived from animals (e.g., “xenografts” such as whole animal organs; animal tissues such as heart valves; naturally occurring or chemically-modified molecules such as collagen, hyaluronic acid, proteins, carbohydrates and others), human donors (e.g., “allografts” such as whole organs; tissues such as bone grafts, skin grafts and others), or from the patients themselves (e.g., “autografts” such as saphenous vein grafts, skin grafts, tendon/ligament/muscle transplants). Medical devices that can be used in procedures in conjunction with the present invention include, but are not restricted to, orthopaedic implants (artificial joints, ligaments and tendons; screws, plates, and other implantable hardware), dental implants, intravascular implants (arterial and venous vascular bypass grafts, hemodialysis access grafts; both autologous and synthetic), skin grafts (autologous, synthetic), tubes, drains, implantable tissue bulking agents, pumps, shunts, sealants, surgical meshes (e.g., hernia repair meshes, tissue scaffolds), fistula treatments, spinal implants (e.g., artificial intervertebral discs, spinal fusion devices, etc.) and the like.
As discussed above, the present invention provides compositions, configurations, methods of manufacturing and methods of using self-retaining systems in surgical procedures which greatly increase their ability to anchor into the surrounding tissue to provide superior holding strength and improve clinical performance.
A. Self-Retaining Sutures
Self-retaining sutures (including barbed sutures) differ from conventional sutures in that they possess numerous tiny tissue retainers (such as barbs) which anchor into the tissue following deployment and resist movement of the suture in a direction opposite to that in which the retainers face, thereby eliminating the need to tie knots to affix adjacent tissues together (a “knotless” closure). By eliminating knot tying, associated complications are eliminated, including, but not limited to (i) spitting (a condition where the suture, usually a knot) pushes through the skin after a subcutaneous closure), (ii) infection (bacteria are often able to attach and grow in the spaces created by a knot), (iii) bulk/mass (a significant amount of suture material left in a wound is the portion that comprises the knot), (iv) slippage (knots can slip or come untied), and (v) irritation (knots serve as a bulk “foreign body” in a wound). Suture loops associated with knot tying may lead to ischemia (they create tension points that can strangulate tissue and limit blood flow to the region) and increased risk of dehiscence or rupture at the surgical wound. Knot tying is also labor intensive and can comprise a significant percentage of the time spent closing a surgical wound. Additional operative procedure time is not only bad for the patient (complication rates rise with time spent under anesthesia), but it also adds to the overall cost of the operation (many surgical procedures are estimated to cost between $15 and $30 per minute of operating time). Thus, knotless sutures not only allow patients to experience an improved clinical outcome, but they also save time and costs associated with extended surgeries and follow-up treatments.
Self-retaining systems for wound closure also result in better approximation of the wound edges, evenly distribute the tension along the length of the wound (reducing areas of tension that can break or lead to ischemia), decrease the bulk of suture material remaining in the wound (by eliminating knots) and reduce spitting (the extrusion of suture material—typically knots—through the surface of the skin. All of these features are thought to reduce scarring, improve cosmesis, and increase wound strength relative to wound closures effected with plain sutures or staples.
The ability of self-retaining sutures to anchor and hold tissues in place even in the absence of tension applied to the suture is a feature that also provides superiority over plain sutures. When closing a wound that is under tension, this advantage manifests itself in several ways: (i) a multiplicity of retainers can dissipate tension along the entire length of the suture (providing hundreds of “anchor” points as opposed to knotted interrupted sutures which concentrate the tension at discrete points; this produces a superior cosmetic result and lessens the chance that the suture will “slip” or pull through); (ii) complicated wound geometries can be closed (circles, arcs, jagged edges) in a uniform manner with more precision and accuracy than can be achieved with interrupted sutures; (iii) they eliminate the need for a “third hand” which is often required for maintaining tension across the wound during traditional suturing and knot tying (to prevent “slippage” when tension is momentarily released during tying); (iv) they are superior in procedures where knot tying is technically difficult, such as in deep wounds or laparoscopic procedures; and (v) they can be used to approximate and hold the wound prior to definitive closure. As a result, self retaining sutures provide easier handling in anatomically tight or deep places (such as the pelvis, abdomen and thorax) and make it easier to approximate tissues in laparoscopic and minimally invasive procedures; all without having to secure the closure via a knot. Greater accuracy allows self-retaining sutures to be used for more complex closures (such as those with diameter mismatches, larger defects or purse string suturing) than can be accomplished with plain sutures.
Self retaining sutures also lend themselves to a variety of specialized indications; for example, they are suitable for tissue elevation procedures where tissue is moved from its previous location and repositioned into a new anatomical location (this is typically performed in cosmetic procedures where “drooping” tissue is elevated and fixed in a more “youthful” position; or where “out-of-position” tissue is moved back to its correct anatomical location). Such procedures include facelifts, brow lifts, breast lifts, buttocks lifts, and so forth.
A self-retaining suture may be unidirectional, having one or more retainers oriented in one direction along the length of the suture thread; or bidirectional, typically having one or more retainers oriented in one direction along a portion of the thread, followed by one or more retainers oriented in another (often opposite) direction over the remainder of the thread (as described with barbed retainers in U.S. Pat. Nos. 5,931,855 and. 6,241,747).
Although any number of sequential or intermittent configurations of retainers are possible, a common form involves a needle at one end, followed by barbs projecting “away” from the needle until the transition point (often the midpoint) of the suture is reached; at the transition point the configuration of barbs reverses itself about 180° (such that the barbs are now facing in the opposite direction) along the remaining length of the suture thread before attaching to a second needle at the opposite end (with the result that the barbs on this portion of the suture also face away from the nearest needle). Put another way, the barbs on both “halves” of a bidirectional self-retaining suture point towards the middle, with a transition segment (lacking retainers) interspersed between them, and with a needle attached to either end.
Despite the multitude of advantages of unidirectional and bidirectional self retaining sutures, there remains a need to improve upon the design of the suture such that a variety of common limitations can be eliminated. Specifically, several problems common to existing self retaining sutures can be addressed by the embodiments of this invention, including, but not limited to: (i) retainers or barbs that are fragile and break (or bend back) when deployed in tissue; (ii) inadequate “hold” provided by the retainers for some surgical procedures; resulting in retainers or barbs do not sufficiently anchor in the surrounding tissue and “pull through;” (iii) insufficient contact between the retainers and the surrounding tissue (often occurring when the thread diameter is too small relative to the diameter of the hole created by a larger needle; this limits the ability of the retainers to contact and “grip” the surrounding tissue); (iv) breakage of the self retaining suture during tensioning and wound apposition; and (v) rotation and slippage of the retainers after deployment. The following self retaining sutures solve many of the aforementioned problems.
B. Tissue Engagement Surface Configurations
The affixation of self-retaining sutures after deployment entails the penetration of retainer ends into the surrounding tissue resulting in tissue being caught between the retainer and the suture body. The inner surface of the retainer that is actually in contact with the tissue that is caught between the retainer and the suture body, herein referred to as the “tissue engagement surface” or “inner retainer surface,” can be adapted to better engage the tissue. With reference to
The tissue engagement surface can be provided with an uneven configuration either during or after the manufacture of the self-retaining suture. In the former case, a method of forming retainers on a suture can include: providing a suture having a longitudinal axis and a circumferential periphery, a cutter, a displacer for pivoting the cutter, the suture, or both about the longitudinal axis; engaging the cutter with the suture; and, cutting an uneven-surfaced escarpment into the periphery of the suture. To achieve a rough surface, the cutter may be a grinding wheel, a burr grinder, have an abrasive surface, etc., while other uneven surface configurations may be achieved with cutters such as, without limitation, arcuate or corrugated blades.
As shown in
Alternatively, an uneven tissue engagement surface and/or suture body surface configuration can be obtained after the manufacture of the self-retaining suture. A method of forming retainers on a suture can include: providing a suture having a longitudinal axis and a circumferential periphery, a cutter, and a displacer for pivoting the cutter, the suture, or both about the longitudinal axis; engaging the cutter with the suture; cutting an escarpment into the periphery of the suture; and rendering uneven at least a portion of at least one (or both) cut surface(s) of the escarpment. The last step may include, without limitation, treating that portion with an abrasive agent, a polymerising agent, an acid etchant, or a base etchant.
C. Diameter Expansion
Both unidirectional and bidirectional self retaining sutures can be provided with an expanded thread section between the two ends. For example, a suture may include an expanded section of the thread such that the diameter of the expanded portion of the thread is greater than the diameter of the end of the suture, or, if the suture is adapted for deployment with a needle that has a greater diameter than the end of the suture, than the diameter of the needle. For sutures adapted for deployment with one or more needles, the diameter of the thread at a specified distance from the needle attachment site (this distance will vary depending upon the clinical indication) is greater than the diameter of the needle that is attached to it. From the point where the barbed suture thread diameter is greatest, the diameter of the thread then tapers down as it approaches the needle attachment site until the thread diameter is equal to, or smaller than, the diameter of the needle to be used to deploy the suture (at the needle's widest point). The rate, distance, degree and length of the tapering of the thread can be adjusted depending upon the clinical indication.
In another aspect, a bidirectional barbed suture may include an expanded segment of the thread which is located at the transition point where the barb configurations change orientation (typically, but not always, located at or near the middle of the thread). The maximum diameter of the suture thread occurs somewhere along the transition segment and is greater than the diameter of either end of the suture, or, in the case of armed sutures, the deployment needle attached to the suture end. In this aspect, the diameter of the thread is greatest at the transition point (typically in the middle) and then tapers down from this segment in both directions towards the needle attachment point until the thread diameter is equal to, or smaller than, the diameter of the ends of the suture or, in the case of armed sutures, the diameter of the needle (at the needle's widest point) attached to it. The rate, distance, degree and length of the tapering of the thread can be adjusted depending upon the clinical indication. In the case of bidirectional self-retaining sutures, one end of the suture is deployed into the tissue at a substantially central first point of the suture path and then the other end is deployed from a second point near the first point but in the opposite direction, in order to avoid engaging the retainers in tissue prior to completing the full deployment of the suture along the desired path. Thus, in the case of bidirectional sutures, a transitional segment of the suture, that segment between a first retainer or plurality of retainers facing away from a first end of the suture and a second retainer or plurality of retainers facing away from a second end of the suture, may be the portion of the suture upon which the greatest tension is exerted and therefore most likely to fail (break and/or pull through), both during deployment and/or after affixation, as the suture is effectively pulled from substantially opposing directions during both deployment and affixation. The portion of the suture upon which the magnitude of the longitudinal forces is greatest can be enhanced to resist those forces by increasing the diameter of the suture thread at that portion; thus reducing the likelihood that it will break. In addition, the larger diameter suture thread will be forced into a smaller diameter “hole” created by the needle (or the smaller diameter suture end); this has the effect of “sinking” the expanded suture thread into the needle track, increasing the likelihood that the retainers will contact and embed in the surrounding tissue, and reducing the probability that the self retaining suture will pull through the tissue when tension is applied to it (something that is more prevalent when the needle track is larger than the thread diameter, as is the case with previously described barbed sutures). This embodiment is not only useful for wound closure applications, but is particularly helpful for tissue retention applications, an example of which is described below in relation to
The expanded thread segment can be created during manufacture of the suture thread (by, for example, extruding a larger amount of suture material for a particular length of a suture thread during an extrusion manufacturing process, cutting or stamping a suture thread with an expanded diameter portion, and so forth), or after the manufacture of the suture thread (by, for example, cutting material away from the ends of a suture thread, adding material to the desired portion of the thread, and so forth).
Referring now to
A use of a bidirectional self-retaining suture 300 having an expanded transition segment 368 is depicted in
Expanded diameter self-retaining sutures are also useful for tissue approximation procedures, that is, those used to bring wounds under high tension closer together to hold them in place while a definitive surface closure is performed; this is illustrated by way of example in
While these examples illustrate the deployment of a self-retaining suture in skin closure and in tissue approximation procedures, it is to be understood that the benefits of using a suture with an expanded diameter along part or all of its transition segment (or, in the case of sutures that are not bidirectional, at some portion away from an end of the suture) can be enjoyed in other suture applications, such as other types of wound closure, tissue repositioning, and so forth. It should also be obvious to one of skill in the art that an expanded diameter segment would be of utility in the creation of any self retaining suture including retainer designs described in the prior art as well as in all the novel retainer designs disclosed in the present invention (in Sections B, D and E).
D. Helical Retainer Configurations
Uneven tension distribution on retainers may also cause suture failure, particularly where retainers are spaced too far apart from one another, the retainer configuration allows “twisting” after deployment, or where there are not enough retainers (or anchorage points) present to provide sufficient holding strength. A self-retaining suture can include improved retainer configurations, such as helical retainers (along the continuous length of which tension is distributed substantially evenly) and scaled retainers (which provide maximal tissue engagement surface area, thereby optimising the tension distribution). For example, with reference to
b also discloses a helical self-retaining suture in the deployment position (that is, the unexpanded position), the suture 401 including a helical retainer 405 disposed along at least part of the suture body 403, the helical retainer 405 including a retainer body 409 and a tissue penetrating edge 411. The retainer 405 also faces in a direction and is adapted for resisting movement of the suture, when in tissue, in an opposite direction from the direction in which it faces. However, helical retainer 404 of suture 400 is chirally opposite to helical retainer 405 of suture 401.
The helical self-retaining sutures of
The pivoting displacement of the cutter and/or suture relative to each other can be effected in one of several ways. For example, one of the cutter or suture may be moved: the cutter may revolve in a path about the circumference of the suture or the suture may be rotated on its longitudinal axis. Alternatively, both suture and cutter may be pivotally displaced about the longitudinal axis of the suture, the suture being rotated while the cutter revolves. In the latter case, suture and cutter may be pivoted either in the same direction or in opposing directions about the longitudinal axis. If both cutter and suture are pivoted in the same direction, the angular velocity at which each is pivoted about the longitudinal axis must differ in order to effect a circumferential escarpment on the suture. Where only one of the two is moved, or both are moved in opposing directions, the pivot velocity does not affect the cutting of the circumferential escarpment, although there may be operational limitations on the pivot velocity.
Similarly, the longitudinal displacement of the suture and cutter relative to one another may be achieved in several ways. If it is desired to only move one of the two, then either the suture can be moved while the cutter remains longitudinally stationary (for example, without limitation, by pulling the suture past the location of the cutter) or the cutter can be moved along the length of the suture. Alternatively, both the cutter and suture can be moved longitudinally, either in opposing directions or in the same direction at differing longitudinal speeds. The “net” velocity of longitudinal displacement (that is, the velocity at which the cutter and suture move longitudinally relative to one another) affects the pitch of the helical circumferential escarpment, and so may be varied to achieve the desired pitch: the greater the net longitudinal displacement velocity, the longer the helical pitch. It is to be understood that the displacer of this method can be either a single component effecting both longitudinal displacement and pivoting displacement or a combination of components to effect both types of displacement.
As the angle at which the cutter cuts into the suture (that is, the transverse cut angle) bears upon the direction in which the tissue retainer will face, the transverse cut angle can be an angle selected in the range between 90° and 180° relative to the longitudinal axis of the suture away from the suture deployment end that the retainer is to face; the transverse cut angle can typically be selected to be greater that 135° and less than 180° from the suture end that the retainer is to face, and can often be in the range of about 160° to about 170° from the suture deployment end. The greater the transverse cut angle, the deeper the cut creating the circumferential escarpment may be without eroding the integrity of the suture. Of course, as the transverse cut angle increases, the thickness of the resulting escarpment decreases, so the selection of the transverse cut angle may depend on the strength and/or resilience and/or rigidity of the suture material, the tissues for which the suture is intended, and so forth. Similarly, the selection of the depth of the circumferential cut may depend on factors including without limitation the aforementioned transverse cut angle, the diameter of the suture, and the tissues for which the suture is intended; exemplary parameters such as transverse cut angles, ratios of cut depth to suture diameter and cut distance to suture diameter and so forth are described in U.S. patent application Ser. No. 10/065,279, incorporated by reference. Where smaller retainer configurations are desired or larger suture diameters are present, a series of parallel helical cuts may be provided, as opposed to a single cut.
A step of cutting a second helical circumferential escarpment can be added to this method; such second helical escarpment may or may not intersect the first helical escarpment. The first and second helical escarpments may have the same or differing pitches (which depend on the rate of longitudinal displacement during the cutting of the escarpment) and cut depths, and/or the same or opposing chiralities. Depending upon the length of the escarpments and the respective transverse cut angles, a difference in pitch or chirality can result in intersection of the escarpments to create an escarpment point. The cutter can be, without limitation, a laser, a blade, a grinding wheel, or a cutting disc; the cutting surface can be abraded or “roughened” on one or both sides (as described in Section B above) to increase the surface area of one or both sides of the retainer. The cutter may be selected to cause the cut surfaces to disengage from one another, in order to facilitate engagement of the retainer with the tissue during affixation of the suture. Where a grinding wheel is selected as the cutter, the grinding action of the wheel removes some of the suture material in forming the escarpment and thereby increases the likelihood that the cut surfaces of the escarpment would disengage from one another during affixation. Further, where the cutter is a blade or cutting wheel, for example, it may be selected to have slightly thicker or wedge-shaped configuration to achieve this separation of cut surfaces. Cutting devices for cutting helical retainers and cutting fixtures for creating relative motion of cutting device and suture body to cut an escarpment in a helical pattern are described in more detail in Section F below.
c discloses a scaled self-retaining suture 450 in an unexpanded position, produced by the foregoing method, wherein two intersecting helical escarpments are cut having substantially similar transverse cut angles, pitches, and cut depths, but opposing chiralities (i.e. the effect of combining 4a and 4b together). The resultant overlap of escarpment points 452 of suture 450 produces a pattern of scale-like retainers 454 having tissue-penetrating edges 456 and tissue-engaging surfaces 458; as the retainers 454 created by this method cover the entire circumferential suture surface on which they are cut, the tension on the suture 450 is optimally distributed and the risk of suture failure minimized. When such retainers 454 of suture 450 engage tissue, retainers 454 flare away from the suture body, as shown in the expanded position in
The foregoing steps may be carried out at the opposite end of the suture to create a bidirectional scaled self-retaining suture. For such a suture, a transition segment at some point between the ends of the suture is left retainer-free; the length of the transitional segment may be selected depending on the purpose of the suture, and the transitional segment may be located at or near the middle of the suture. Thus, to manufacture bidirectional scaled self-retaining sutures, the first pair of helical escarpments is cut along one end of the suture to a selected point some distance from the other suture end while the second pair of helical escarpments is cut to a selected point away from the first pair, so as to avoid having the first and second pair of escarpments from overlapping with one another and thereby providing a retainer-free transitional segment. For some bidirectional scaled self-retaining sutures, the orientation of one pair of helical escarpments at one end is about 180.degree. in orientation from the other pair of helical escarpments at the other end, thus creating an identical “mirrored” pattern of helical escarpments. Where smaller retainer configurations are desired or larger suture diameters are present, a series of parallel helical cuts may be provided, as opposed to a single cut. Both ends of the resulting bidirectional scaled self-retaining suture can function as suture deployment ends, and can therefore be adapted for attachment to deployment devices such as suture needles or for direct deployment into tissue without a deployment device. Referring now to
If desired, a scaled self-retaining suture may be modified by rounding off or blunting the escarpment points. Referring now to
The bidirectional sutures described herein may be further provided with an expanded transition segment for to further resist movement in tissue. Referring now to
In like fashion, the bidirectional scaled self-retaining suture 900 in
Bidirectional scaled self-retaining sutures may further be provided with expanded diameter transitional segments as described in Section C herein, increased surface area provided by the tissue engagement surface configurations described in Section B, and secondary retainer structure configurations as described in Section E.
E. Secondary Retainer Structure Configurations
To further reduce issues of uneven tension distribution or insufficient tissue engagement from arising and potentially leading to suture failure, self-retaining sutures may be provided with a secondary retainer structure, that is, secondary retainers upon the primary retainers. Secondary retainers further increase the surface area of the suture and thereby increase the amount of interaction between the suture and tissue. Moreover, providing secondary retainers on the primary retainers increases the total number of retainers on the suture (and thus the total number of points of tissue penetration) without a reduction in suture tensile strength that may occur by cutting additional primary retainers into the suture body. The increase in the number of retainers and the increase in the suture's tissue engagement surface area results in better distribution of tension on the suture and increased tissue hold.
Referring to
Self-retaining sutures having secondary retainers associated with primary retainers may further be provided with secondary retainers along the suture body, as disclosed in
Yet another secondary retainer structure is illustrated in
F. Manufacture of Self-Retaining Sutures
Suture threads described herein may be produced by any suitable method, including without limitation injection moulding, stamping, cutting, laser, extrusion, and so forth. With respect to cutting, polymeric thread or filaments may be manufactured or purchased for the suture body, and the retainers can be subsequently cut onto the suture body; they may be hand-cut, laser-cut, or mechanically machine-cut using blades, cutting wheels, grinding wheels, and so forth. The sutures may be made of any suitable biocompatible material, and may be further treated with any suitable biocompatible material, whether to enhance the sutures' strength, resilience, longevity, or other qualities, or to equip the sutures to fulfill additional functions besides joining tissues together, repositioning tissues, or attaching foreign elements to tissues.
As described above, helical or spiral self-retaining sutures can be produced by a method including (i) providing a suture having a longitudinal axis and a circumference; a cutter; and, a displacer for longitudinally displacing and pivoting about the longitudinal axis at least one of the cutter and suture relative to one another; (ii) placing the cutter and suture into cutting engagement at a transverse cut angle; and, (iii) cutting a helical circumferential escarpment about the suture.
As shown in
Roller 1416 and rotary cutting head 1412 are mounted to a floating armature 1430 which is pushed into contact with suture body 403 by springs 1432. The drive mechanism 1434 connecting motor 1418 and rotary cutting head 1412 allows movement of rotary cutting head 1412 without binding. Rotary cutting head 1412 is driven at a very high rotation rate compared to the translation and rotation of suture body 403. In alternative embodiments other cutting devices may be used including knives, abrasive wheels, lasers and the like. Alternative mechanisms may also be utilized to control the depth of cut including an electronically controlled sensor/servo system or other mechanical “following” systems. Where the diameter of suture body 403 is sufficiently uniform, the distance between roller 1416 and cutter support 1420 may be fixed rather than varying with the diameter of the suture body.
An anvil or cutter support 1420 is provided on the opposite side of suture body 403 from cutting device 1410 to support the suture body 403 during the cutting operation. The cutter support 1420 is designed to allow suture body 403 to translate longitudinally (arrow 1404) and rotate (arrow 1402) relative to cutting device 1410 but not to move laterally or vertically while passing through cutting device 1410. Cutter support 1420 thus maintains suture body 403 in the correct alignment with rotary cutting head 1412 during the cutting action. Suture body 403 is held between roller 1416 and cutter support 1420. Roller 1416 may also function to prevent lateral and vertical motion of suture body 403.
In order for cutting device 1410 to create a helical escarpment in the surface of suture body 403 one of cutting device 1410 or suture body 403 is rotated (arrow 1402) relative to the longitudinal axis of suture body 403 and translated (arrow 1404) along the longitudinal axis of suture body 403 at the same time. Alternatively, both suture body 403 and cutting device 1410 may be rotated about the longitudinal axis of the suture body 403, the suture body 403 being rotated while the cutting device 1410 revolves. In the latter case, suture body 403 and cutting device 1410 may be rotated either in the same direction or in opposing directions about the longitudinal axis of suture body 403. If both cutting device 1410 and suture body 403 are rotated in the same direction, the angular velocity at which each is rotated about the longitudinal axis must differ in order to effect a circumferential escarpment on the suture.
The speed of translation compared to the relative rate of rotation of cutting device 1410 and suture body 403 controls the pitch of the helical retainer 405. The pitch of the helical retainer 405 is the distance between turns. The pitch of helical retainer 405 is shown in
In order to form a helical retainer, a mechanism is used to generate the desired rate of rotation and speed of translation of the suture body 403 relative to the cutting device 1410.
c shows an alternative cutting fixture 1460 for forming a helical retainer 405 disposed along a suture body 403 of a self-retaining suture 401. Cutting fixture 1460 includes cutting device 1410 along with a mechanism for rotating suture body 403 and translating suture body 403 relative to cutting device 1410. As shown in
c shows an alternative cutting fixture 1460 for forming a helical retainer 405 disposed along a suture body 403 of a self-retaining suture 401. Cutting fixture 1460 includes cutting device 1410 along with a mechanism for rotating suture body 403 and translating suture body 403 relative to cutting device 1410. As shown in
e shows an alternative cutting fixture 1490 for forming a helical or spiral retainer 405 disposed along a suture body 403 of a self-retaining suture. Cutting fixture 1490 includes cutting device 1410 along with a mechanism for rotating cutting device 1410 relative to suture body 403 and translating suture body 403 relative to cutting device 1410. As shown in
Still alternatively, the mechanisms of
As, shown in
a shows an alternative cutting device 1510 that may be used in the cutting fixtures of
b shows an end view of cutting device 1510 illustrating the entrance aperture 1506 into cutting device 1510. Entrance aperture 1506 into cutting device 1510 is defined by the space between supports 1520 and 1522. Supports 1520 and 1522 are each provided with a polished radius or polished chamfer 1521 to guide suture body 403 (position shown by dashed line) into aperture 1506 without abrading suture body 403. Rotary cutting blade 1512 can seen protruding into aperture 1506 adjacent support 1521. In alternative embodiments a plurality of cutting blades may be provide in order to cut a plurality of helical retainers at the same time. As suture body 403 enters aperture 1506 (into the page) suture body 403 rotates in the direction of arrow 1508 relative to cutting device. 1510. Note that either the suture body 403 or the cutting device 1510 may be rotated to achieve the desired relative rotation of cutting device 1510 and suture body 403.
c shows another alternative cutting device 1530 that may be used in the cutting fixtures of
Self-retaining sutures described herein may also incorporate materials that further promote tissue engagement. In addition to tissue engagement at the retainers, use of tissue engagement-promoting materials in at least part of the suture bodies (whether or not such materials also make up all or part of the retainers) can enhance the ability of the sutures to stay in place. One such class of tissue engagement-promoting materials are porous polymers that can be extruded to form suture bodies, including both microporous polymers and polymers that can be extruded with bubbles (whether bioabsorbable or nonbioabsorbable). A suture synthesized with such materials can have a three-dimensional lattice structure that increases tissue engagement surface area and permits tissue infiltration into the suture body itself, thus having a primary structure that promotes successful suture use. Moreover, by optimizing pore size, fibroblast ingrowth can be encouraged, further facilitating the suture to be anchored in the tissue.
One such microporous polymer is ePTFE (expanded polytetra-fluoroethylene). Self-retaining incorporating ePTFE (and related microporous materials) are well-suited to uses requiring a strong and permanent lift (such as breast lifts, face lifts, and other tissue repositioning procedures), as tissue infiltration of the suture results in improved fixation and engraftment of the suture and the surrounding tissue thus providing superior hold and greater longevity of the lift.
Additionally, self-retaining sutures described herein may be provided with compositions to promote healing and prevent undesirable effects such as scar formation, infection, pain, and so forth. This can be accomplished in a variety of manners, including for example: (a) by directly affixing to the suture a formulation (e.g., by either spraying the suture with a polymer/drug film, or by dipping the suture into a polymer/drug solution), (b) by coating the suture with a substance such as a hydrogel which will in turn absorb the composition, (c) by interweaving formulation-coated thread (or the polymer itself formed into a thread) into the suture structure in the case of multi-filamentary sutures, (d) by inserting the suture into a sleeve or mesh which is comprised of, or coated with, a formulation, or (e) constructing the suture itself with a composition. Such compositions may include without limitation anti-proliferative agents, anti-angiogenic agents, anti-infective agents, fibrosis-inducing agents, anti-scarring agents, lubricious agents, echogenic agents, anti-inflammatory agents, cell cycle inhibitors, analgesics, and anti-microtubule agents. For example, a composition can be applied to the suture before the retainers are formed, so that when the retainers engage, the engaging surface is substantially free of the coating. In this way, tissue being sutured contacts a coated surface of the suture as the suture is introduced, but when the retainer engages, a non-coated surface of the retainer contacts the tissue. Alternatively, the suture may be coated after or during formation of retainers on the suture if, for example, a fully-coated rather than selectively-coated suture is desired. In yet another alternative, a suture may be selectively coated either during or after formation of retainers by exposing only selected portions of the suture to the coating. The particular purpose to which the suture is to be put or the composition may determine whether a fully-coated or selectively-coated suture is appropriate; for example, with lubricious coatings, it may be desirable to selectively coat the suture, leaving, for instance, the tissue-engaging surfaces of the sutures uncoated in order to prevent the tissue engagement function of those surfaces from being impaired. On the other hand, coatings such as those comprising such compounds as anti-infective agents may suitably be applied to the entire suture, while coatings such as those comprising fibrosing agents may suitably be applied to all or part of the suture (such as the tissue-engaging surfaces). The purpose of the suture may also determine the sort of coating that is applied to the suture; for example, self-retaining sutures having anti-proliferative coatings may be used in closing tumour excision sites, while self-retaining sutures with fibrosing coatings may be used in tissue repositioning procedures and those having anti-scarring coatings may be used for wound closure on the skin. As well, the structure of the suture may influence the choice and extent of coating; for example, sutures having an expanded segment may include a fibrosis-inducing composition on the expanded segment to further secure the segment in position in the tissue. Coatings may also include a plurality of compositions either together or on different portions of the suture, where the multiple compositions can be selected either for different purposes (such as combinations of analgesics, anti-infective and anti-scarring agents) or for their synergistic effects.
G. Clinical Uses
In addition to the general wound closure and soft tissue repair applications described in the preceding sections, self retaining sutures can be used in a variety of other indications.
Self-retaining sutures described herein may be used in various dental procedures, i.e., oral and maxillofacial surgical procedures and thus may be referred to as “self-retaining dental sutures.” The above-mentioned procedures include, but are not limited to, oral surgery (e.g., removal of impacted or broken teeth), surgery to provide bone augmentation, surgery to repair dentofacial deformities, repair following trauma (e.g., facial bone fractures and injuries), surgical treatment of odontogenic and non-odontogenic tumors, reconstructive surgeries, repair of cleft lip or cleft palate, congenital craniofacial deformities, and esthetic facial surgery. Self-retaining dental sutures may be degradable or non-degradable, and may typically range in size from USP 2-0 to USP 6-0.
Self-retaining sutures described herein may also be used in tissue repositioning surgical procedures and thus may be referred to as “self-retaining tissue repositioning sutures”. Such surgical procedures include, without limitation, face lifts, neck lifts, brow lifts, thigh lifts, and breast lifts. Self-retaining sutures used in tissue repositioning procedures may vary depending on the tissue being repositioned; for example, sutures with larger and further spaced-apart retainers may be suitably employed with relatively soft tissues such as fatty tissues.
Self-retaining sutures described herein may also be used in microsurgical procedures that are performed under a surgical microscope (and thus may be referred to as “self-retaining microsutures”). Such surgical procedures include, but are not limited to, reattachment and repair of peripheral nerves, spinal microsurgery, microsurgery of the hand, various plastic microsurgical procedures (e.g., facial reconstruction), microsurgery of the male or female reproductive systems, and various types of reconstructive microsurgery. Microsurgical reconstruction is used for complex reconstructive surgery problems when other options such as primary closure, healing by secondary intention, skin grafting, local flap transfer, and distant flap transfer are not adequate. Self-retaining microsutures have a very small caliber, often as small as USP 9-0 or USP 10-0, and may have an attached needle of corresponding size. They may be degradable or non-degradable.
Self-retaining sutures as described herein may be used in similarly small caliber ranges for ophthalmic surgical procedures and thus may be referred to as “ophthalmic self-retaining sutures”. Such procedures include but are not limited to keratoplasty, cataract, and vitreous retinal microsurgical procedures. Ophthalmic self-retaining sutures may be degradable or non-degradable, and have an attached needle of correspondingly-small caliber.
Self retaining sutures can be used in a variety of veterinary applications for a wide number of surgical and traumatic purposes in animal health.
Although the present invention has been shown and described in detail with regard to only a few exemplary embodiments of the invention, it should be understood by those skilled in the art that it is not intended to limit the invention to the specific embodiments disclosed. Various modifications, omissions, and additions may be made to the disclosed embodiments without materially departing from the novel teachings and advantages of the invention, particularly in light of the foregoing teachings. Accordingly, it is intended to cover all such modifications, omissions, additions, and equivalents as may be included within the spirit and scope of the invention as defined by the following claims.
This application claims priority to U.S. Provisional Application No. 60/911,814, filed Apr. 13, 2007, which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
709392 | Brown | Sep 1902 | A |
733723 | Lukens | Jul 1903 | A |
789401 | Acheson | May 1905 | A |
816026 | Meier | Mar 1906 | A |
879758 | Foster | Feb 1908 | A |
1142510 | Engle | Jun 1915 | A |
1248825 | Dederrer | Dec 1917 | A |
1321011 | Cottes | Nov 1919 | A |
1558037 | Morton | Oct 1925 | A |
1728316 | Wachenfeldt | Sep 1929 | A |
1886721 | O'Brien | Nov 1932 | A |
2094578 | Blumenthal et al. | Oct 1937 | A |
2201610 | Dawson | May 1940 | A |
2232142 | Schumann | Feb 1941 | A |
2254620 | Miller | Sep 1941 | A |
2347956 | Lansing | May 1944 | A |
2355907 | Cox | Aug 1944 | A |
2421193 | Gardner | May 1947 | A |
2452734 | Costelow | Nov 1948 | A |
2472009 | Gardner | May 1949 | A |
2480271 | Sumner | Aug 1949 | A |
2572936 | Kulp et al. | Oct 1951 | A |
2684070 | Kelsey | Jul 1954 | A |
2736964 | Lieberman | Mar 1956 | A |
2779083 | Eaton | Jan 1957 | A |
2814296 | Everett | Nov 1957 | A |
2817339 | Sullivan | Dec 1957 | A |
2830366 | Chisena | Apr 1958 | A |
2866256 | Matlin | Dec 1958 | A |
2910067 | White | Oct 1959 | A |
2928395 | Forbes et al. | Mar 1960 | A |
2988028 | Alcamo | Jun 1961 | A |
3003155 | Mielzynski | Oct 1961 | A |
3066452 | Bott et al. | Dec 1962 | A |
3066673 | Bott et al. | Dec 1962 | A |
3068869 | Shelden | Dec 1962 | A |
3068870 | Levin | Dec 1962 | A |
3082523 | Modes et al. | Mar 1963 | A |
3123077 | Alcamo | Mar 1964 | A |
3166072 | Sullivan | Jan 1965 | A |
3187752 | Glick | Jun 1965 | A |
3206018 | Lewis et al. | Sep 1965 | A |
3209652 | Burgsmueller | Oct 1965 | A |
3209754 | Brown | Oct 1965 | A |
3212187 | Benedict | Oct 1965 | A |
3214810 | Mathison | Nov 1965 | A |
3221746 | Noble | Dec 1965 | A |
3234636 | Brown | Feb 1966 | A |
3273562 | Brown | Sep 1966 | A |
3352191 | Crawford | Nov 1967 | A |
3378010 | Codling et al. | Apr 1968 | A |
3385299 | Le Roy | May 1968 | A |
3394704 | Dery | Jul 1968 | A |
3494006 | Brumlik | Feb 1970 | A |
3522637 | Brumlik | Aug 1970 | A |
3525340 | Gilbert | Aug 1970 | A |
3527223 | Shein | Sep 1970 | A |
3545608 | Berger et al. | Dec 1970 | A |
3557795 | Hirsch | Jan 1971 | A |
3570497 | Lemole | Mar 1971 | A |
3586002 | Wood | Jun 1971 | A |
3608095 | Barry | Sep 1971 | A |
3608539 | Miller | Sep 1971 | A |
3618447 | Goins | Nov 1971 | A |
3646615 | Ness | Mar 1972 | A |
3683926 | Suzuki | Aug 1972 | A |
3700433 | Duhl | Oct 1972 | A |
3716058 | Tanner, Jr. | Feb 1973 | A |
3720055 | de Mestral et al. | Mar 1973 | A |
3748701 | De Mestral | Jul 1973 | A |
3762418 | Wasson | Oct 1973 | A |
3825010 | McDonald | Jul 1974 | A |
3833972 | Brumlik | Sep 1974 | A |
3845641 | Waller | Nov 1974 | A |
3847156 | Trumble | Nov 1974 | A |
3889322 | Brumlik | Jun 1975 | A |
3918455 | Coplan | Nov 1975 | A |
3922455 | Brumlik | Nov 1975 | A |
3941164 | Musgrave | Mar 1976 | A |
3951261 | Mandel et al. | Apr 1976 | A |
3963031 | Hunter | Jun 1976 | A |
3977937 | Candor | Aug 1976 | A |
3980177 | McGregor | Sep 1976 | A |
3981051 | Brumlik | Sep 1976 | A |
3981307 | Borysko | Sep 1976 | A |
3985138 | Jarvik | Oct 1976 | A |
3985227 | Thyen et al. | Oct 1976 | A |
3987797 | Stephenson | Oct 1976 | A |
3990144 | Schwartz | Nov 1976 | A |
4006747 | Kronenthal et al. | Feb 1977 | A |
4008303 | Glick et al. | Feb 1977 | A |
4027608 | Arbuckle | Jun 1977 | A |
4043344 | Landi | Aug 1977 | A |
4052988 | Doddi et al. | Oct 1977 | A |
D246911 | Bess, Jr. et al. | Jan 1978 | S |
4069825 | Akiyama | Jan 1978 | A |
4073298 | Le Roy | Feb 1978 | A |
4137921 | Okuzumi et al. | Feb 1979 | A |
4182340 | Spencer | Jan 1980 | A |
4186239 | Mize et al. | Jan 1980 | A |
4198734 | Brumlik | Apr 1980 | A |
4204541 | Kapitanov | May 1980 | A |
4204542 | Bokros et al. | May 1980 | A |
4259959 | Walker | Apr 1981 | A |
4278374 | Wolosianski | Jul 1981 | A |
4300424 | Flinn et al. | Nov 1981 | A |
4313448 | Stokes | Feb 1982 | A |
4316469 | Kapitanov | Feb 1982 | A |
4317451 | Cerwin et al. | Mar 1982 | A |
4345362 | de Givry | Aug 1982 | A |
4372293 | Vijil-Rosales | Feb 1983 | A |
4428376 | Mericle et al. | Jan 1984 | A |
4430998 | Harvey et al. | Feb 1984 | A |
4434796 | Karapetian et al. | Mar 1984 | A |
4449298 | Patz | May 1984 | A |
4454875 | Pratt et al. | Jun 1984 | A |
4467805 | Fukuda | Aug 1984 | A |
4490326 | Beroff et al. | Dec 1984 | A |
4492075 | Faure | Jan 1985 | A |
4493323 | Albright et al. | Jan 1985 | A |
4505274 | Speelman | Mar 1985 | A |
4510934 | Batra | Apr 1985 | A |
4531522 | Bedi et al. | Jul 1985 | A |
4532926 | O'Holla | Aug 1985 | A |
4535772 | Sheehan | Aug 1985 | A |
4548202 | Duncan | Oct 1985 | A |
4553544 | Nomoto et al. | Nov 1985 | A |
4610250 | Green | Sep 1986 | A |
4610251 | Kumar | Sep 1986 | A |
4635637 | Schreiber | Jan 1987 | A |
4637380 | Orejola | Jan 1987 | A |
4653486 | Coker | Mar 1987 | A |
4669473 | Richards et al. | Jun 1987 | A |
4676245 | Fukuda | Jun 1987 | A |
4689882 | Lorenz | Sep 1987 | A |
4702250 | Ovil et al. | Oct 1987 | A |
4712553 | MacGregor | Dec 1987 | A |
4719917 | Barrows et al. | Jan 1988 | A |
4741330 | Hayhurst | May 1988 | A |
4750910 | Takayanagi et al. | Jun 1988 | A |
4751621 | Jenkins | Jun 1988 | A |
4776337 | Palmaz | Oct 1988 | A |
4832025 | Coates | May 1989 | A |
4841960 | Garner | Jun 1989 | A |
4865026 | Barrett | Sep 1989 | A |
4873976 | Schreiber | Oct 1989 | A |
4887601 | Richards | Dec 1989 | A |
4895148 | Bays et al. | Jan 1990 | A |
4898156 | Gatturna et al. | Feb 1990 | A |
4899743 | Nicholson et al. | Feb 1990 | A |
4900605 | Thorgersen et al. | Feb 1990 | A |
4905367 | Pinchuk et al. | Mar 1990 | A |
4930945 | Arai et al. | Jun 1990 | A |
4932962 | Yoon et al. | Jun 1990 | A |
4946468 | Li | Aug 1990 | A |
4948444 | Schutz et al. | Aug 1990 | A |
4950258 | Kawai et al. | Aug 1990 | A |
4950285 | Wilk | Aug 1990 | A |
4968315 | Gatturna et al. | Nov 1990 | A |
4976715 | Bays et al. | Dec 1990 | A |
4979956 | Silvestrini et al. | Dec 1990 | A |
4981149 | Yoon et al. | Jan 1991 | A |
4994073 | Green | Feb 1991 | A |
4994084 | Brennan | Feb 1991 | A |
4997439 | Chen | Mar 1991 | A |
5002550 | Li | Mar 1991 | A |
5002562 | Oberlander | Mar 1991 | A |
5007921 | Brown | Apr 1991 | A |
5007922 | Chen et al. | Apr 1991 | A |
5026390 | Brown | Jun 1991 | A |
5037422 | Hayhurst et al. | Aug 1991 | A |
5037433 | Wilk et al. | Aug 1991 | A |
5041129 | Hayhurst et al. | Aug 1991 | A |
5046513 | Gatturna et al. | Sep 1991 | A |
5047047 | Yoon | Sep 1991 | A |
5053047 | Yoon | Oct 1991 | A |
5084063 | Korthoff | Jan 1992 | A |
5089010 | Korthoff | Feb 1992 | A |
5101968 | Henderson et al. | Apr 1992 | A |
5102418 | Granger et al. | Apr 1992 | A |
5102421 | Anspach, Jr. | Apr 1992 | A |
5103073 | Danilov et al. | Apr 1992 | A |
5112344 | Petros | May 1992 | A |
5123911 | Granger et al. | Jun 1992 | A |
5123913 | Wilk et al. | Jun 1992 | A |
5123919 | Sauter et al. | Jun 1992 | A |
5127413 | Ebert | Jul 1992 | A |
5133738 | Korthoff et al. | Jul 1992 | A |
5141520 | Goble et al. | Aug 1992 | A |
5147382 | Gertzman et al. | Sep 1992 | A |
5156615 | Korthoff et al. | Oct 1992 | A |
5156788 | Chesterfield | Oct 1992 | A |
5176692 | Wilk et al. | Jan 1993 | A |
5179964 | Cook | Jan 1993 | A |
5192274 | Bierman | Mar 1993 | A |
5192302 | Kensey et al. | Mar 1993 | A |
5192303 | Gatturna et al. | Mar 1993 | A |
5197597 | Leary et al. | Mar 1993 | A |
5201326 | Kubicki et al. | Apr 1993 | A |
5207679 | Li | May 1993 | A |
5207694 | Broome | May 1993 | A |
5217486 | Rice et al. | Jun 1993 | A |
5217494 | Coggins et al. | Jun 1993 | A |
5222508 | Contarini | Jun 1993 | A |
5222976 | Yoon | Jun 1993 | A |
5224946 | Hayhurst et al. | Jul 1993 | A |
5234006 | Eaton et al. | Aug 1993 | A |
5242457 | Akopov et al. | Sep 1993 | A |
5246441 | Ross et al. | Sep 1993 | A |
5249673 | Sinn | Oct 1993 | A |
5258013 | Granger et al. | Nov 1993 | A |
5259846 | Granger et al. | Nov 1993 | A |
5263973 | Cook | Nov 1993 | A |
5269783 | Sander | Dec 1993 | A |
5282832 | Toso et al. | Feb 1994 | A |
5292326 | Green et al. | Mar 1994 | A |
5306288 | Granger et al. | Apr 1994 | A |
5306290 | Martins et al. | Apr 1994 | A |
5312422 | Trott | May 1994 | A |
5320629 | Noda et al. | Jun 1994 | A |
5330488 | Goldrath | Jul 1994 | A |
5330503 | Yoon | Jul 1994 | A |
5336239 | Gimpelson | Aug 1994 | A |
5341922 | Cerwin et al. | Aug 1994 | A |
5342376 | Ruff | Aug 1994 | A |
5342395 | Jarrett et al. | Aug 1994 | A |
5350385 | Christy | Sep 1994 | A |
5352515 | Jarrett et al. | Oct 1994 | A |
5354271 | Voda | Oct 1994 | A |
5354298 | Lee et al. | Oct 1994 | A |
5358511 | Gatturna et al. | Oct 1994 | A |
5363556 | Banholzer et al. | Nov 1994 | A |
5372146 | Branch | Dec 1994 | A |
5374268 | Sander | Dec 1994 | A |
5374278 | Chesterfield et al. | Dec 1994 | A |
5380334 | Torrie et al. | Jan 1995 | A |
5391173 | Wilk | Feb 1995 | A |
5395126 | Tresslar | Mar 1995 | A |
5403346 | Loeser | Apr 1995 | A |
5411523 | Goble | May 1995 | A |
5414988 | Dipalma et al. | May 1995 | A |
5417691 | Hayhurst | May 1995 | A |
5425746 | Proto et al. | Jun 1995 | A |
5425747 | Brotz | Jun 1995 | A |
5437680 | Yoon et al. | Aug 1995 | A |
5450860 | O'Connor | Sep 1995 | A |
5451461 | Broyer | Sep 1995 | A |
5462561 | Voda | Oct 1995 | A |
5464422 | Silverman | Nov 1995 | A |
5464426 | Bonutti | Nov 1995 | A |
5464427 | Curtis et al. | Nov 1995 | A |
5472452 | Trott | Dec 1995 | A |
5478353 | Yoon | Dec 1995 | A |
5480403 | Lee et al. | Jan 1996 | A |
5480411 | Liu et al. | Jan 1996 | A |
5484451 | Akopov et al. | Jan 1996 | A |
5486197 | Le et al. | Jan 1996 | A |
5494154 | Ainsworth et al. | Feb 1996 | A |
5500000 | Feagin et al. | Mar 1996 | A |
5500991 | Demarest et al. | Mar 1996 | A |
5520084 | Chesterfield et al. | May 1996 | A |
5520691 | Branch et al. | May 1996 | A |
5522845 | Wenstrom, Jr. et al. | Jun 1996 | A |
5527342 | Pietrzak et al. | Jun 1996 | A |
5531760 | Alwafaie | Jul 1996 | A |
5531761 | Yoon | Jul 1996 | A |
5531790 | Frechet et al. | Jul 1996 | A |
5533982 | Rizk et al. | Jul 1996 | A |
5536582 | Prasad et al. | Jul 1996 | A |
5540705 | Meade et al. | Jul 1996 | A |
5540718 | Bartlett | Jul 1996 | A |
5546957 | Heske | Aug 1996 | A |
5549631 | Bonutti | Aug 1996 | A |
5554171 | Gatturna et al. | Sep 1996 | A |
5566822 | Scanlon | Oct 1996 | A |
5569272 | Reed et al. | Oct 1996 | A |
5571139 | Jenkins, Jr. | Nov 1996 | A |
5571175 | Vanney et al. | Nov 1996 | A |
5571216 | Anderson | Nov 1996 | A |
5573543 | Akopov et al. | Nov 1996 | A |
5584859 | Brotz | Dec 1996 | A |
5593424 | Northrup III, et al. | Jan 1997 | A |
5601557 | Hayhurst | Feb 1997 | A |
5626590 | Wilk | May 1997 | A |
5626611 | Liu et al. | May 1997 | A |
5632753 | Loeser | May 1997 | A |
5643288 | Thompson | Jul 1997 | A |
5643295 | Yoon | Jul 1997 | A |
5643319 | Green et al. | Jul 1997 | A |
5645568 | Chervitz et al. | Jul 1997 | A |
5647874 | Hayhurst | Jul 1997 | A |
5649939 | Reddick | Jul 1997 | A |
5653716 | Malo et al. | Aug 1997 | A |
5662714 | Charvin et al. | Sep 1997 | A |
5669935 | Rosenman et al. | Sep 1997 | A |
5676675 | Grice | Oct 1997 | A |
D386583 | Ferragamo et al. | Nov 1997 | S |
5683417 | Cooper | Nov 1997 | A |
D387161 | Ferragamo et al. | Dec 1997 | S |
5693072 | McIntosh | Dec 1997 | A |
5695879 | Goldmann et al. | Dec 1997 | A |
5697976 | Chesterfield et al. | Dec 1997 | A |
5702397 | Goble et al. | Dec 1997 | A |
5702462 | Oberlander | Dec 1997 | A |
5709692 | Mollenauer et al. | Jan 1998 | A |
5716358 | Ochoa et al. | Feb 1998 | A |
5716376 | Roby et al. | Feb 1998 | A |
5722991 | Colligan | Mar 1998 | A |
5723008 | Gordon | Mar 1998 | A |
5725557 | Gatturna et al. | Mar 1998 | A |
5728114 | Evans | Mar 1998 | A |
5731855 | Koyama et al. | Mar 1998 | A |
5741277 | Gordon et al. | Apr 1998 | A |
5744151 | Capelli | Apr 1998 | A |
5763411 | Edwardson et al. | Jun 1998 | A |
5765560 | Verkerke et al. | Jun 1998 | A |
5766246 | Mulhauser et al. | Jun 1998 | A |
5779719 | Klein et al. | Jul 1998 | A |
5782864 | Lizardi | Jul 1998 | A |
5807403 | Beyar et al. | Sep 1998 | A |
5810853 | Yoon | Sep 1998 | A |
5814051 | Wenstrom, Jr. | Sep 1998 | A |
5843087 | Jensen et al. | Dec 1998 | A |
5843178 | Vanney et al. | Dec 1998 | A |
5855619 | Caplan et al. | Jan 1999 | A |
5863360 | Wood et al. | Jan 1999 | A |
5884859 | Ma | Mar 1999 | A |
5887594 | Locicero, III | Mar 1999 | A |
5891166 | Schervinsky | Apr 1999 | A |
5893856 | Jacob et al. | Apr 1999 | A |
5895395 | Yeung | Apr 1999 | A |
5895413 | Nordstrom | Apr 1999 | A |
5897572 | Schulsinger et al. | Apr 1999 | A |
5899911 | Carter | May 1999 | A |
5916224 | Esplin | Jun 1999 | A |
5919234 | Lemperle et al. | Jul 1999 | A |
5921982 | Lesh et al. | Jul 1999 | A |
5925078 | Anderson | Jul 1999 | A |
5931855 | Buncke | Aug 1999 | A |
5935138 | McJames, II et al. | Aug 1999 | A |
5938668 | Scirica et al. | Aug 1999 | A |
5941899 | Granger et al. | Aug 1999 | A |
5950505 | Locher | Sep 1999 | A |
5950633 | Lynch et al. | Sep 1999 | A |
5954747 | Clark | Sep 1999 | A |
5964765 | Fenton, Jr. et al. | Oct 1999 | A |
5964783 | Grafton et al. | Oct 1999 | A |
5968097 | Frechet et al. | Oct 1999 | A |
5972024 | Northrup, III et al. | Oct 1999 | A |
5984933 | Yoon | Nov 1999 | A |
5993459 | Larsen et al. | Nov 1999 | A |
6001111 | Sepetka et al. | Dec 1999 | A |
6012216 | Esteves et al. | Jan 2000 | A |
6015410 | Tormala et al. | Jan 2000 | A |
6024757 | Haase et al. | Feb 2000 | A |
6027523 | Schmieding | Feb 2000 | A |
6039741 | Meislin | Mar 2000 | A |
5320629 | Noda et al. | May 2000 | B1 |
6056778 | Grafton et al. | May 2000 | A |
6063105 | Totakura | May 2000 | A |
6071292 | Makower et al. | Jun 2000 | A |
6074419 | Healy et al. | Jun 2000 | A |
6076255 | Shikakubo et al. | Jun 2000 | A |
6083244 | Lubbers et al. | Jul 2000 | A |
6102947 | Gordon | Aug 2000 | A |
6106544 | Brazeau | Aug 2000 | A |
6106545 | Egan | Aug 2000 | A |
6110484 | Sierra | Aug 2000 | A |
6129741 | Wurster et al. | Oct 2000 | A |
D433753 | Weiss | Nov 2000 | S |
6146406 | Shluzas et al. | Nov 2000 | A |
6146407 | Krebs | Nov 2000 | A |
6149660 | Laufer et al. | Nov 2000 | A |
6159234 | Bonutti et al. | Dec 2000 | A |
6160084 | Langer et al. | Dec 2000 | A |
6163948 | Esteves et al. | Dec 2000 | A |
6165203 | Krebs | Dec 2000 | A |
6168633 | Shoher et al. | Jan 2001 | B1 |
6174324 | Egan et al. | Jan 2001 | B1 |
6183499 | Fischer et al. | Feb 2001 | B1 |
6187095 | Labrecque et al. | Feb 2001 | B1 |
6203565 | Bonutti et al. | Mar 2001 | B1 |
6206908 | Roby | Mar 2001 | B1 |
6214030 | Matsutani et al. | Apr 2001 | B1 |
6231911 | Steinback et al. | May 2001 | B1 |
6235869 | Roby et al. | May 2001 | B1 |
6241747 | Ruff | Jun 2001 | B1 |
6251143 | Schwartz et al. | Jun 2001 | B1 |
6264675 | Brotz | Jul 2001 | B1 |
6267772 | Mulhauser et al. | Jul 2001 | B1 |
6270517 | Brotz | Aug 2001 | B1 |
6315788 | Roby | Nov 2001 | B1 |
6319231 | Andrulitis | Nov 2001 | B1 |
6322581 | Fukuda et al. | Nov 2001 | B1 |
6334865 | Redmond et al. | Jan 2002 | B1 |
6383201 | Dong | May 2002 | B1 |
6387363 | Gruskin | May 2002 | B1 |
6388043 | Langer et al. | May 2002 | B1 |
6395029 | Levy | May 2002 | B1 |
D462766 | Jacobs et al. | Sep 2002 | S |
6443962 | Gaber | Sep 2002 | B1 |
6463719 | Dey et al. | Oct 2002 | B2 |
6471715 | Weiss | Oct 2002 | B1 |
6478809 | Brotz | Nov 2002 | B1 |
6485503 | Jacobs et al. | Nov 2002 | B2 |
6491701 | Tierney et al. | Dec 2002 | B2 |
6491714 | Bennett | Dec 2002 | B1 |
6494898 | Roby et al. | Dec 2002 | B1 |
6495127 | Wallace et al. | Dec 2002 | B1 |
RE37963 | Thal | Jan 2003 | E |
6506190 | Walshe | Jan 2003 | B1 |
6506197 | Rollero et al. | Jan 2003 | B1 |
6511488 | Marshall et al. | Jan 2003 | B1 |
6514265 | Ho et al. | Feb 2003 | B2 |
6527795 | Lizardi | Mar 2003 | B1 |
6548002 | Gresser et al. | Apr 2003 | B2 |
6548569 | Williams et al. | Apr 2003 | B1 |
6551343 | Tormala et al. | Apr 2003 | B1 |
6554802 | Pearson et al. | Apr 2003 | B1 |
6565597 | Fearnot et al. | May 2003 | B1 |
6592609 | Bonutti | Jul 2003 | B1 |
6596296 | Nelson et al. | Jul 2003 | B1 |
6599310 | Leung et al. | Jul 2003 | B2 |
6607541 | Gardiner et al. | Aug 2003 | B1 |
6610078 | Bru-Magniez et al. | Aug 2003 | B1 |
6613059 | Schaller et al. | Sep 2003 | B2 |
6613254 | Shiffer | Sep 2003 | B1 |
6616982 | Merrill et al. | Sep 2003 | B2 |
6623492 | Berube et al. | Sep 2003 | B1 |
6626930 | Allen et al. | Sep 2003 | B1 |
6632245 | Kim | Oct 2003 | B2 |
6641592 | Sauer et al. | Nov 2003 | B1 |
6641593 | Schaller et al. | Nov 2003 | B1 |
6645226 | Jacobs et al. | Nov 2003 | B1 |
6645227 | Fallin et al. | Nov 2003 | B2 |
6645228 | Renz | Nov 2003 | B2 |
6648921 | Anderson et al. | Nov 2003 | B2 |
6656182 | Hayhurst | Dec 2003 | B1 |
6689153 | Skiba | Feb 2004 | B1 |
6689166 | Laurencin et al. | Feb 2004 | B2 |
6692761 | Mahmood et al. | Feb 2004 | B2 |
6702844 | Lazarus | Mar 2004 | B1 |
6712830 | Esplin | Mar 2004 | B2 |
6712859 | Rousseau et al. | Mar 2004 | B2 |
6716234 | Grafton et al. | Apr 2004 | B2 |
6720402 | Langer et al. | Apr 2004 | B2 |
6726705 | Peterson et al. | Apr 2004 | B2 |
6746443 | Morley et al. | Jun 2004 | B1 |
6746458 | Cloud | Jun 2004 | B1 |
6749616 | Nath | Jun 2004 | B1 |
6773450 | Leung et al. | Aug 2004 | B2 |
6783554 | Amara et al. | Aug 2004 | B2 |
6814748 | Baker et al. | Nov 2004 | B1 |
6818010 | Eichhorn et al. | Nov 2004 | B2 |
6838493 | Williams et al. | Jan 2005 | B2 |
6848152 | Genova et al. | Feb 2005 | B2 |
6852825 | Lendlein et al. | Feb 2005 | B2 |
6858222 | Nelson et al. | Feb 2005 | B2 |
6860891 | Schulze | Mar 2005 | B2 |
6860901 | Baker et al. | Mar 2005 | B1 |
6867248 | Martin et al. | Mar 2005 | B1 |
6877934 | Gainer | Apr 2005 | B2 |
6881766 | Hain | Apr 2005 | B2 |
6893452 | Jacobs et al. | May 2005 | B2 |
6905484 | Buckman et al. | Jun 2005 | B2 |
6911035 | Blomme | Jun 2005 | B1 |
6911037 | Gainor et al. | Jun 2005 | B2 |
6913607 | Ainsworth et al. | Jul 2005 | B2 |
6921811 | Zamora et al. | Jul 2005 | B2 |
6923819 | Meade et al. | Aug 2005 | B2 |
6945021 | Michel | Sep 2005 | B2 |
6945980 | Nguyen et al. | Sep 2005 | B2 |
6960221 | Ho et al. | Nov 2005 | B2 |
6960233 | Berg et al. | Nov 2005 | B1 |
6974450 | Weber et al. | Dec 2005 | B2 |
6981983 | Rosenblatt et al. | Jan 2006 | B1 |
6984241 | Lubbers et al. | Jan 2006 | B2 |
6986780 | Rudnick et al. | Jan 2006 | B2 |
6991643 | Saadat | Jan 2006 | B2 |
6996880 | Kurtz, Jr. | Feb 2006 | B2 |
7021316 | Leiboff | Apr 2006 | B2 |
7033379 | Peterson | Apr 2006 | B2 |
7033603 | Nelson et al. | Apr 2006 | B2 |
7037984 | Lendlein et al. | May 2006 | B2 |
7048748 | Ustuner | May 2006 | B1 |
7056331 | Kaplan et al. | Jun 2006 | B2 |
7056333 | Walshe | Jun 2006 | B2 |
7057135 | Li | Jun 2006 | B2 |
7063716 | Cunningham | Jun 2006 | B2 |
7070610 | Im et al. | Jul 2006 | B2 |
7081135 | Smith et al. | Jul 2006 | B2 |
7083637 | Tannhauser | Aug 2006 | B1 |
7083648 | Yu et al. | Aug 2006 | B2 |
7107090 | Salisbury, Jr. et al. | Sep 2006 | B2 |
7112214 | Peterson et al. | Sep 2006 | B2 |
7125403 | Julian et al. | Oct 2006 | B2 |
7125413 | Grigoryants et al. | Oct 2006 | B2 |
D532107 | Peterson et al. | Nov 2006 | S |
7138441 | Zhang | Nov 2006 | B1 |
7141302 | Mueller et al. | Nov 2006 | B2 |
7144401 | Yamamoto et al. | Dec 2006 | B2 |
7144412 | Wolf et al. | Dec 2006 | B2 |
7144415 | DelRio et al. | Dec 2006 | B2 |
7150757 | Fallin et al. | Dec 2006 | B2 |
7156858 | Schuldt-Hempe et al. | Jan 2007 | B2 |
7156862 | Jacobs et al. | Jan 2007 | B2 |
7160312 | Saadat | Jan 2007 | B2 |
7166570 | Hunter et al. | Jan 2007 | B2 |
7172595 | Goble | Feb 2007 | B1 |
7172615 | Morriss et al. | Feb 2007 | B2 |
7186262 | Saadat | Mar 2007 | B2 |
7195634 | Schmielding et al. | Mar 2007 | B2 |
7211088 | Grafton et al | May 2007 | B2 |
7214230 | Brock et al. | May 2007 | B2 |
7217744 | Lendlein et al. | May 2007 | B2 |
7225512 | Genova et al. | Jun 2007 | B2 |
7226468 | Ruff | Jun 2007 | B2 |
7232447 | Gellman et al. | Jun 2007 | B2 |
7244270 | Lesh et al. | Jul 2007 | B2 |
7279612 | Heaton et al. | Oct 2007 | B1 |
7297142 | Brock | Nov 2007 | B2 |
7322105 | Lewis | Jan 2008 | B2 |
7371253 | Leung et al. | May 2008 | B2 |
7513904 | Sulamanidze et al. | Apr 2009 | B2 |
7514095 | Nelson et al. | Apr 2009 | B2 |
7582105 | Kolster | Sep 2009 | B2 |
7601164 | Wu | Oct 2009 | B2 |
7624487 | Trull et al. | Dec 2009 | B2 |
7645293 | Martinek et al. | Jan 2010 | B2 |
7806908 | Ruff | Oct 2010 | B2 |
7845356 | Paraschac et al. | Dec 2010 | B2 |
7857829 | Kaplan et al. | Dec 2010 | B2 |
7879072 | Bonutti et al. | Feb 2011 | B2 |
7913365 | Genova et al. | Mar 2011 | B2 |
7919112 | Pathak et al. | Apr 2011 | B2 |
7996967 | Genova et al. | Aug 2011 | B2 |
7996968 | Genova et al. | Aug 2011 | B2 |
8011072 | Genova et al. | Sep 2011 | B2 |
8015678 | Genova | Sep 2011 | B2 |
8020263 | Genova et al. | Sep 2011 | B2 |
8028387 | Genova et al. | Oct 2011 | B2 |
8028388 | Genova et al. | Oct 2011 | B2 |
8032996 | Trull et al. | Oct 2011 | B2 |
8118834 | Goraltchouk et al. | Feb 2012 | B1 |
8216273 | Goraltchouk et al. | Jul 2012 | B1 |
8226684 | Nawrocki et al. | Jul 2012 | B2 |
8308761 | Brailovski et al. | Nov 2012 | B2 |
8615856 | Gelbart | Dec 2013 | B1 |
20010011187 | Pavcnik et al. | Aug 2001 | A1 |
20010018592 | Schaller et al. | Aug 2001 | A1 |
20010018599 | D'Aversa et al. | Aug 2001 | A1 |
20010039450 | Pavcnik et al. | Nov 2001 | A1 |
20010044637 | Jacobs et al. | Nov 2001 | A1 |
20010051807 | Grafton | Dec 2001 | A1 |
20010051815 | Esplin | Dec 2001 | A1 |
20020007218 | Cauthen | Jan 2002 | A1 |
20020022861 | Jacobs et al. | Feb 2002 | A1 |
20020029011 | Dyer | Mar 2002 | A1 |
20020029066 | Foerster | Mar 2002 | A1 |
20020069617 | Dey et al. | Jun 2002 | A1 |
20020077448 | Antal et al. | Jun 2002 | A1 |
20020077631 | Lubbers et al. | Jun 2002 | A1 |
20020095164 | Andreas et al. | Jul 2002 | A1 |
20020099394 | Houser et al. | Jul 2002 | A1 |
20020111641 | Peterson et al. | Aug 2002 | A1 |
20020111688 | Cauthen | Aug 2002 | A1 |
20020138009 | Brockway et al. | Sep 2002 | A1 |
20020151932 | Bryant et al. | Oct 2002 | A1 |
20020151980 | Cauthen | Oct 2002 | A1 |
20020161168 | Shalaby et al. | Oct 2002 | A1 |
20020173807 | Jacobs | Nov 2002 | A1 |
20020173822 | Justin et al. | Nov 2002 | A1 |
20020179718 | Murokh et al. | Dec 2002 | A1 |
20030014077 | Leung et al. | Jan 2003 | A1 |
20030040795 | Elson et al. | Feb 2003 | A1 |
20030041426 | Genova et al. | Mar 2003 | A1 |
20030065360 | Jacobs et al. | Apr 2003 | A1 |
20030065402 | Anderson et al. | Apr 2003 | A1 |
20030069602 | Jacobs et al. | Apr 2003 | A1 |
20030074021 | Morriss et al. | Apr 2003 | A1 |
20030074023 | Kaplan et al. | Apr 2003 | A1 |
20030078604 | Walshe | Apr 2003 | A1 |
20030088270 | Lubbers et al. | May 2003 | A1 |
20030097150 | Fallin et al. | May 2003 | A1 |
20030105489 | Eichhorn et al. | Jun 2003 | A1 |
20030149447 | Morency et al. | Aug 2003 | A1 |
20030158604 | Cauthen, III et al. | Aug 2003 | A1 |
20030167072 | Oberlander | Sep 2003 | A1 |
20030199923 | Khairkhahan et al. | Oct 2003 | A1 |
20030203003 | Nelson et al. | Oct 2003 | A1 |
20030204193 | Gabriel et al. | Oct 2003 | A1 |
20030204195 | Keane et al. | Oct 2003 | A1 |
20030225424 | Benderev | Dec 2003 | A1 |
20030229361 | Jackson | Dec 2003 | A1 |
20030236550 | Peterson et al. | Dec 2003 | A1 |
20030236551 | Peterson | Dec 2003 | A1 |
20040006353 | Bosley, Jr. et al. | Jan 2004 | A1 |
20040010275 | Jacobs et al. | Jan 2004 | A1 |
20040010276 | Jacobs et al. | Jan 2004 | A1 |
20040015187 | Lendlein et al. | Jan 2004 | A1 |
20040024169 | Shalaby et al. | Feb 2004 | A1 |
20040024420 | Lubbers et al. | Feb 2004 | A1 |
20040028655 | Nelson et al. | Feb 2004 | A1 |
20040030354 | Leung et al. | Feb 2004 | A1 |
20040039415 | Zamierowski | Feb 2004 | A1 |
20040049224 | Buehlmann et al. | Mar 2004 | A1 |
20040059370 | Greene, Jr. et al. | Mar 2004 | A1 |
20040059377 | Peterson et al. | Mar 2004 | A1 |
20040059378 | Peterson et al. | Mar 2004 | A1 |
20040060409 | Leung et al. | Apr 2004 | A1 |
20040060410 | Leung et al. | Apr 2004 | A1 |
20040068293 | Scalzo et al. | Apr 2004 | A1 |
20040068294 | Scalzo et al. | Apr 2004 | A1 |
20040088003 | Leung et al. | May 2004 | A1 |
20040093023 | Allen et al. | May 2004 | A1 |
20040093028 | Ruff | May 2004 | A1 |
20040098051 | Fallin et al. | May 2004 | A1 |
20040106949 | Cohn et al. | Jun 2004 | A1 |
20040116620 | Shalaby et al. | Jun 2004 | A1 |
20040138683 | Shelton et al. | Jul 2004 | A1 |
20040153153 | Elson et al. | Aug 2004 | A1 |
20040167572 | Roth et al. | Aug 2004 | A1 |
20040167575 | Roby | Aug 2004 | A1 |
20040186487 | Klein et al. | Sep 2004 | A1 |
20040193191 | Starksen et al. | Sep 2004 | A1 |
20040193217 | Lubbers et al. | Sep 2004 | A1 |
20040193257 | Wu et al. | Sep 2004 | A1 |
20040226427 | Trull et al. | Nov 2004 | A1 |
20040230223 | Bonutti et al. | Nov 2004 | A1 |
20040237736 | Genova et al. | Dec 2004 | A1 |
20040254609 | Esplin | Dec 2004 | A1 |
20040260340 | Jacobs et al. | Dec 2004 | A1 |
20040265282 | Wright et al. | Dec 2004 | A1 |
20040267309 | Garvin | Dec 2004 | A1 |
20050004601 | Kong et al. | Jan 2005 | A1 |
20050004602 | Hart et al. | Jan 2005 | A1 |
20050033324 | Phan | Feb 2005 | A1 |
20050033367 | Leung et al. | Feb 2005 | A1 |
20050034431 | Dey et al. | Feb 2005 | A1 |
20050038472 | Furst | Feb 2005 | A1 |
20050049636 | Leiboff | Mar 2005 | A1 |
20050055051 | Grafton | Mar 2005 | A1 |
20050059984 | Chanduszko et al. | Mar 2005 | A1 |
20050065533 | Magen et al. | Mar 2005 | A1 |
20050070959 | Cichocki, Jr. | Mar 2005 | A1 |
20050080455 | Schmieding et al. | Apr 2005 | A1 |
20050085857 | Peterson et al. | Apr 2005 | A1 |
20050096698 | Lederman | May 2005 | A1 |
20050106211 | Nelson et al. | May 2005 | A1 |
20050113936 | Brustad et al. | May 2005 | A1 |
20050119694 | Jacobs et al. | Jun 2005 | A1 |
20050125020 | Meade et al. | Jun 2005 | A1 |
20050125034 | Cichocki, Jr. | Jun 2005 | A1 |
20050125035 | Cichocki, Jr. | Jun 2005 | A1 |
20050149064 | Peterson et al. | Jul 2005 | A1 |
20050149118 | Koyfman et al. | Jul 2005 | A1 |
20050154255 | Jacobs | Jul 2005 | A1 |
20050171561 | Songer et al. | Aug 2005 | A1 |
20050177190 | Zamierowski | Aug 2005 | A1 |
20050181009 | Hunter et al. | Aug 2005 | A1 |
20050182444 | Peterson et al. | Aug 2005 | A1 |
20050182445 | Zamierowski | Aug 2005 | A1 |
20050186247 | Hunter et al. | Aug 2005 | A1 |
20050197699 | Jacobs et al. | Sep 2005 | A1 |
20050199249 | Karram | Sep 2005 | A1 |
20050203576 | Sulamanidze et al. | Sep 2005 | A1 |
20050209542 | Jacobs et al. | Sep 2005 | A1 |
20050209612 | Nakao | Sep 2005 | A1 |
20050234510 | Zamierowski | Oct 2005 | A1 |
20050240220 | Zamierowski | Oct 2005 | A1 |
20050240224 | Wu | Oct 2005 | A1 |
20050267531 | Ruff et al. | Dec 2005 | A1 |
20050267532 | Wu | Dec 2005 | A1 |
20050277984 | Long | Dec 2005 | A1 |
20050283246 | Cauthen et al. | Dec 2005 | A1 |
20060020272 | Gildenberg | Jan 2006 | A1 |
20060030884 | Yeung et al. | Feb 2006 | A1 |
20060036266 | Sulamanidze et al. | Feb 2006 | A1 |
20060058470 | Rizk | Mar 2006 | A1 |
20060058574 | Priewe et al. | Mar 2006 | A1 |
20060058799 | Elson et al. | Mar 2006 | A1 |
20060058844 | White et al. | Mar 2006 | A1 |
20060063476 | Dore | Mar 2006 | A1 |
20060064115 | Allen et al. | Mar 2006 | A1 |
20060064116 | Allen et al. | Mar 2006 | A1 |
20060064127 | Fallin et al. | Mar 2006 | A1 |
20060079469 | Anderson et al. | Apr 2006 | A1 |
20060079935 | Kolster | Apr 2006 | A1 |
20060085016 | Eremia | Apr 2006 | A1 |
20060089525 | Mamo et al. | Apr 2006 | A1 |
20060089672 | Martinek | Apr 2006 | A1 |
20060111734 | Kaplan et al. | May 2006 | A1 |
20060111742 | Kaplan et al. | May 2006 | A1 |
20060116503 | Lendlein et al. | Jun 2006 | A1 |
20060122608 | Fallin et al. | Jun 2006 | A1 |
20060135994 | Ruff et al. | Jun 2006 | A1 |
20060135995 | Ruff et al. | Jun 2006 | A1 |
20060140999 | Lendlein et al. | Jun 2006 | A1 |
20060142784 | Kontos | Jun 2006 | A1 |
20060193769 | Nelson et al. | Aug 2006 | A1 |
20060194721 | Allen | Aug 2006 | A1 |
20060200062 | Saadat | Sep 2006 | A1 |
20060207612 | Jackson et al. | Sep 2006 | A1 |
20060229671 | Steiner et al. | Oct 2006 | A1 |
20060235445 | Birk et al. | Oct 2006 | A1 |
20060235447 | Walshe | Oct 2006 | A1 |
20060235516 | Cavazzoni | Oct 2006 | A1 |
20060241658 | Cerundolo | Oct 2006 | A1 |
20060249405 | Cerwin et al. | Nov 2006 | A1 |
20060253126 | Bjerken et al. | Nov 2006 | A1 |
20060257629 | Lendlein et al. | Nov 2006 | A1 |
20060258938 | Hoffman et al. | Nov 2006 | A1 |
20060272979 | Lubbers et al. | Dec 2006 | A1 |
20060276808 | Arnal et al. | Dec 2006 | A1 |
20060282099 | Stokes et al. | Dec 2006 | A1 |
20060286289 | Prajapati et al. | Dec 2006 | A1 |
20060287675 | Prajapati et al. | Dec 2006 | A1 |
20060287676 | Prajapati et al. | Dec 2006 | A1 |
20060293710 | Foerster et al. | Dec 2006 | A1 |
20070005109 | Popadiuk et al. | Jan 2007 | A1 |
20070005110 | Collier et al. | Jan 2007 | A1 |
20070016251 | Roby | Jan 2007 | A1 |
20070021779 | Garvin et al. | Jan 2007 | A1 |
20070027475 | Pagedas | Feb 2007 | A1 |
20070038249 | Kolster | Feb 2007 | A1 |
20070065663 | Trull et al. | Mar 2007 | A1 |
20070088135 | Lendlein et al. | Apr 2007 | A1 |
20070088391 | McAlexander et al. | Apr 2007 | A1 |
20070134292 | Suokas et al. | Jun 2007 | A1 |
20070135840 | Schmieding | Jun 2007 | A1 |
20070135843 | Burkhart | Jun 2007 | A1 |
20070151961 | Kleine et al. | Jul 2007 | A1 |
20070156175 | Weadock et al. | Jul 2007 | A1 |
20070167958 | Sulamanidze et al. | Jul 2007 | A1 |
20070187861 | Genova et al. | Aug 2007 | A1 |
20070208355 | Ruff | Sep 2007 | A1 |
20070208377 | Kaplan et al. | Sep 2007 | A1 |
20070213770 | Dreyfuss | Sep 2007 | A1 |
20070219587 | Accardo | Sep 2007 | A1 |
20070224237 | Hwang et al. | Sep 2007 | A1 |
20070225642 | Houser et al. | Sep 2007 | A1 |
20070225761 | Shetty | Sep 2007 | A1 |
20070225763 | Zwolinski et al. | Sep 2007 | A1 |
20070227914 | Cerwin et al. | Oct 2007 | A1 |
20070233188 | Hunt et al. | Oct 2007 | A1 |
20070239206 | Shelton, IV et al. | Oct 2007 | A1 |
20070239207 | Beramendi | Oct 2007 | A1 |
20070257395 | Lindh et al. | Nov 2007 | A1 |
20070282247 | Desai et al. | Dec 2007 | A1 |
20070293892 | Takasu | Dec 2007 | A1 |
20080004490 | Bosley, Jr. et al. | Jan 2008 | A1 |
20080004603 | Larkin et al. | Jan 2008 | A1 |
20080009838 | Schena et al. | Jan 2008 | A1 |
20080009888 | Ewers et al. | Jan 2008 | A1 |
20080009902 | Hunter et al. | Jan 2008 | A1 |
20080027273 | Gutterman | Jan 2008 | A1 |
20080027486 | Jones et al. | Jan 2008 | A1 |
20080046094 | Han et al. | Feb 2008 | A1 |
20080058869 | Stopek et al. | Mar 2008 | A1 |
20080064839 | Hadba et al. | Mar 2008 | A1 |
20080066764 | Paraschac et al. | Mar 2008 | A1 |
20080066765 | Paraschac et al. | Mar 2008 | A1 |
20080066766 | Paraschac et al. | Mar 2008 | A1 |
20080066767 | Paraschac et al. | Mar 2008 | A1 |
20080077181 | Jones et al. | Mar 2008 | A1 |
20080082113 | Bishop et al. | Apr 2008 | A1 |
20080082129 | Jones et al. | Apr 2008 | A1 |
20080086169 | Jones et al. | Apr 2008 | A1 |
20080086170 | Jones et al. | Apr 2008 | A1 |
20080109036 | Stopek et al. | May 2008 | A1 |
20080131692 | Rolland et al. | Jun 2008 | A1 |
20080132943 | Maiorino et al. | Jun 2008 | A1 |
20080169059 | Messersmith et al. | Jul 2008 | A1 |
20080195147 | Stopek | Aug 2008 | A1 |
20080208358 | Bellamkonda et al. | Aug 2008 | A1 |
20080215072 | Kelly | Sep 2008 | A1 |
20080221618 | Chen et al. | Sep 2008 | A1 |
20080234731 | Leung et al. | Sep 2008 | A1 |
20080248216 | Yeung et al. | Oct 2008 | A1 |
20080255611 | Hunter | Oct 2008 | A1 |
20080255612 | Hunter | Oct 2008 | A1 |
20080262542 | Sulamanidze et al. | Oct 2008 | A1 |
20080281338 | Wohlert et al. | Nov 2008 | A1 |
20080281357 | Sung et al. | Nov 2008 | A1 |
20080312688 | Nawrocki et al. | Dec 2008 | A1 |
20090012560 | Hunter et al. | Jan 2009 | A1 |
20090018577 | Leung et al. | Jan 2009 | A1 |
20090043336 | Yuan et al. | Feb 2009 | A1 |
20090076543 | Maiorino et al. | Mar 2009 | A1 |
20090082856 | Flanagan | Mar 2009 | A1 |
20090088835 | Wang | Apr 2009 | A1 |
20090099597 | Isse | Apr 2009 | A1 |
20090105753 | Greenhalgh et al. | Apr 2009 | A1 |
20090107965 | D'Agostino | Apr 2009 | A1 |
20090112236 | Stopek | Apr 2009 | A1 |
20090112259 | D'Agostino | Apr 2009 | A1 |
20090143819 | D'Agostino | Jun 2009 | A1 |
20090200487 | Maiorino et al. | Aug 2009 | A1 |
20090210006 | Cohen et al. | Aug 2009 | A1 |
20090216253 | Bell et al. | Aug 2009 | A1 |
20090226500 | Avelar et al. | Sep 2009 | A1 |
20090248066 | Wilkie | Oct 2009 | A1 |
20090248067 | Maiorino | Oct 2009 | A1 |
20090248070 | Kosa et al. | Oct 2009 | A1 |
20090250356 | Kirsch et al. | Oct 2009 | A1 |
20090250588 | Robeson et al. | Oct 2009 | A1 |
20090259233 | Bogart et al. | Oct 2009 | A1 |
20090259251 | Cohen | Oct 2009 | A1 |
20090287245 | Ostrovsky et al. | Nov 2009 | A1 |
20090299407 | Yuan et al. | Dec 2009 | A1 |
20090299408 | Schuldt-Hempe et al. | Dec 2009 | A1 |
20090306710 | Lindh et al. | Dec 2009 | A1 |
20090318958 | Ochiai | Dec 2009 | A1 |
20100021516 | McKay | Jan 2010 | A1 |
20100023055 | Rousseau | Jan 2010 | A1 |
20100057123 | D'Agostino et al. | Mar 2010 | A1 |
20100063540 | Maiorino | Mar 2010 | A1 |
20100071833 | Maiorino | Mar 2010 | A1 |
20100087855 | Leung et al. | Apr 2010 | A1 |
20100101707 | Maiorino et al. | Apr 2010 | A1 |
20100140115 | Kirsch | Jun 2010 | A1 |
20100160961 | Nawrocki et al. | Jun 2010 | A1 |
20100163056 | Tschopp et al. | Jul 2010 | A1 |
20100198257 | Stopek et al. | Aug 2010 | A1 |
20100211097 | Hadba et al. | Aug 2010 | A1 |
20100211098 | Hadba et al. | Aug 2010 | A1 |
20100230300 | Hunter et al. | Sep 2010 | A1 |
20100239635 | McClain et al. | Sep 2010 | A1 |
20100292718 | Sholev et al. | Nov 2010 | A1 |
20100294103 | Genova et al. | Nov 2010 | A1 |
20100294104 | Genova et al. | Nov 2010 | A1 |
20100294105 | Genova et al. | Nov 2010 | A1 |
20100294106 | Genova et al. | Nov 2010 | A1 |
20100294107 | Genova et al. | Nov 2010 | A1 |
20100298637 | Ruff | Nov 2010 | A1 |
20100298639 | Leung et al. | Nov 2010 | A1 |
20100298848 | Leung et al. | Nov 2010 | A1 |
20100298867 | Ruff | Nov 2010 | A1 |
20100298868 | Ruff | Nov 2010 | A1 |
20100298871 | Ruff et al. | Nov 2010 | A1 |
20100298878 | Leung et al. | Nov 2010 | A1 |
20100298879 | Leung et al. | Nov 2010 | A1 |
20100298880 | Leung et al. | Nov 2010 | A1 |
20100313723 | Genova et al. | Dec 2010 | A1 |
20100313729 | Genova et al. | Dec 2010 | A1 |
20100313730 | Genova et al. | Dec 2010 | A1 |
20100318122 | Leung et al. | Dec 2010 | A1 |
20100318123 | Leung et al. | Dec 2010 | A1 |
20100318124 | Leung et al. | Dec 2010 | A1 |
20110009902 | Leung et al. | Jan 2011 | A1 |
20110046669 | Goraltchouk et al. | Feb 2011 | A1 |
20110093010 | Genova et al. | Apr 2011 | A1 |
20110106152 | Kozlowski | May 2011 | A1 |
20110130774 | Criscuolo et al. | Jun 2011 | A1 |
20110166597 | Herrmann et al. | Jul 2011 | A1 |
20120109188 | Viola | May 2012 | A1 |
Number | Date | Country |
---|---|---|
1014364 | Sep 2003 | BE |
2309844 | Dec 1996 | CA |
2640420 | Sep 2004 | CN |
P 1 810 800 | Jun 1970 | DE |
03227984 | Feb 1984 | DE |
43 02 895 | Aug 1994 | DE |
19618891 | Apr 1997 | DE |
19833703 | Feb 2000 | DE |
10245025 | Apr 2004 | DE |
10 2005 004317 | Jun 2006 | DE |
0121362 | Sep 1987 | EP |
0329787 | Aug 1989 | EP |
0428253 | May 1991 | EP |
0464479 | Jan 1992 | EP |
0513713 | May 1992 | EP |
0513736 | Nov 1992 | EP |
0558993 | Sep 1993 | EP |
0574707 | Dec 1993 | EP |
0576337 | Dec 1993 | EP |
0612504 | Aug 1994 | EP |
0632999 | Jan 1995 | EP |
0464480 | Mar 1995 | EP |
0664198 | Jul 1995 | EP |
0673624 | Sep 1995 | EP |
0705567 | Apr 1996 | EP |
0755656 | Jan 1997 | EP |
0576337 | Mar 1997 | EP |
826337 | Mar 1998 | EP |
0913123 | May 1999 | EP |
0916310 | May 1999 | EP |
1075843 | Feb 2001 | EP |
0839499 | Sep 2003 | EP |
1525851 | Apr 2005 | EP |
1532942 | May 2005 | EP |
1 726 317 | Nov 2006 | EP |
0991359 | Nov 2007 | EP |
2036502 | Mar 2009 | EP |
1948261 | Nov 2010 | EP |
2338421 | Nov 2012 | EP |
2619129 | Feb 1989 | FR |
2693108 | Jan 1994 | FR |
9208059 | Mar 1997 | FR |
267007 | Mar 1927 | GB |
1091282 | Nov 1967 | GB |
1428560 | Jul 1973 | GB |
1506362 | Apr 1978 | GB |
1508627 | Apr 1978 | GB |
1506362 | Apr 1978 | JP |
054116419 | Sep 1979 | JP |
63-500702 | Mar 1988 | JP |
63288146 | Nov 1988 | JP |
001113091 | May 1989 | JP |
003-165751 | Jul 1991 | JP |
4-96758 | Mar 1992 | JP |
4-226642 | Aug 1992 | JP |
004-266749 | Sep 1992 | JP |
9-103477 | Apr 1997 | JP |
10-511009 | Oct 1997 | JP |
10-503389 | Mar 1998 | JP |
410085225 | Apr 1998 | JP |
11-313826 | Nov 1999 | JP |
011332828 | Dec 1999 | JP |
2002-59235 | Feb 2002 | JP |
2002-511308 | Apr 2002 | JP |
2003-275217 | Sep 2003 | JP |
2004-530524 | Oct 2004 | JP |
2005-500119 | Jan 2005 | JP |
2006-516902 | Jul 2006 | JP |
2006-517112 | Jul 2006 | JP |
2009-118967 | Jun 2009 | JP |
10-2005-0072908 | Jul 2005 | KR |
6013299 | Feb 2006 | KR |
2006-59142 | Jun 2006 | KR |
501224 | Mar 2002 | NZ |
531262 | Dec 2005 | NZ |
2139690 | Jul 1992 | RU |
2175855 | Nov 2001 | RU |
2241389 | Dec 2004 | RU |
2268752 | Jan 2006 | RU |
1745214 | Aug 1992 | SU |
1752358 | Oct 1999 | SU |
8600020 | Jan 1986 | WO |
8701270 | Mar 1987 | WO |
WO 8809157 | Dec 1988 | WO |
WO 8905618 | Jun 1989 | WO |
WO 9009149 | Aug 1990 | WO |
9014795 | Dec 1990 | WO |
9222336 | Jul 1992 | WO |
9606565 | Aug 1992 | WO |
9516399 | Jun 1995 | WO |
9529637 | Nov 1995 | WO |
WO 9852473 | Nov 1998 | WO |
WO 9855031 | Dec 1998 | WO |
WO 9921488 | May 1999 | WO |
WO 9933401 | Jul 1999 | WO |
9952478 | Oct 1999 | WO |
9959477 | Nov 1999 | WO |
0960600 | Dec 1999 | WO |
WO 9962431 | Dec 1999 | WO |
0051685 | Sep 2000 | WO |
WO 0051658 | Sep 2000 | WO |
WO 0106952 | Feb 2001 | WO |
0156626 | Aug 2001 | WO |
03003925 | Jan 2003 | WO |
WO 03001979 | Jan 2003 | WO |
WO 03017850 | Mar 2003 | WO |
WO 03045255 | Jun 2003 | WO |
WO 03077772 | Sep 2003 | WO |
WO 03092758 | Nov 2003 | WO |
03103733 | Dec 2003 | WO |
WO 03103972 | Dec 2003 | WO |
WO 03105703 | Dec 2003 | WO |
2004014236 | Feb 2004 | WO |
2004030517 | Apr 2004 | WO |
WO 2004030520 | Apr 2004 | WO |
WO 2004030704 | Apr 2004 | WO |
WO 2004030705 | Apr 2004 | WO |
WO 2004062459 | Jul 2004 | WO |
2004100801 | Nov 2004 | WO |
WO 2004112853 | Dec 2004 | WO |
2005016176 | Feb 2005 | WO |
2005074913 | Aug 2005 | WO |
WO 2005096955 | Oct 2005 | WO |
WO 2005096956 | Oct 2005 | WO |
2005112787 | Dec 2005 | WO |
WO 2006005144 | Jan 2006 | WO |
WO 2006012128 | Feb 2006 | WO |
2006037399 | Apr 2006 | WO |
WO 2006061868 | Jun 2006 | WO |
2006082060 | Aug 2006 | WO |
WO 2006079469 | Aug 2006 | WO |
WO 2006099703 | Sep 2006 | WO |
2006138300 | Dec 2006 | WO |
WO 2007005291 | Jan 2007 | WO |
WO 2007005296 | Jan 2007 | WO |
2007038837 | Apr 2007 | WO |
WO 2007053812 | May 2007 | WO |
2007089864 | Aug 2007 | WO |
WO 2007112024 | Oct 2007 | WO |
WO 2007133103 | Nov 2007 | WO |
2007145614 | Dec 2007 | WO |
2008128113 | Oct 2008 | WO |
2009042841 | Apr 2009 | WO |
2009068252 | Jun 2009 | WO |
2009087105 | Jul 2009 | WO |
2009097556 | Aug 2009 | WO |
2009151876 | Dec 2009 | WO |
2010052007 | May 2010 | WO |
2011053375 | May 2011 | WO |
2011139916 | Nov 2011 | WO |
2011140283 | Nov 2011 | WO |
Entry |
---|
Bellin et al., “Polymeric triple-shape materials”, Proceedings of the National Academy of Sciences of the United States of America Nov. 28, 2006; 2103(48):18043-18047. |
Bunnell, S., “Gig pull-out suture for tendons.” J Bone Joint Surg Am. Jul. 1954;36-A(4):850-1. |
Dattillo, Jr., Philip Paul, “Knotless Bi-directional Barbed Absorbable Surgical Suture”, Dissertation submitted to the Graduate Faculty of North Carolina State University Textile Management and Technology Nov. 2002, 75 pages. |
Delorenzi, C.L., “Barbed Sutures: Rationale and Technique.” Aesthetic Surg J. Mar. 2006 26(2): 223-229. |
Han, Hongtao et al., “Mating and Piercing Micromechanical Structures for Surface Bonding Applications”, Proceedings of the 1991 Micro Electro Mechanical Systems (MEMS '91), An Investigation of Micro Structures, Sensors, Actuators, Machines and Robots, Feb. 1991, pp. 253-258. |
Ingle, Nilesh P et al., “Barbed Suture Anchoring Strength: Applicability to Dissimilar Polymeric Materials”, College of Textiles, North Carolina State University, 7th World Biomaterials Congress 2004, 1 page. |
Ingle, Nilesh P et al., “Testing the Tissue-holding Capacity of Barbed Sutures”, College of Textiles, North Carolina State University, Fiber Science—The Next Generation Oct. 17-19, 2005, New Jersey Institute of Technology, Newark, NJ, 4 pages. |
International Search Report for PCT/US2007/074658 dated Jun. 12, 2007, 4 pages. |
International Search Report for PCT/US2008/060127 dated Sep. 23, 2008, 8 pages. |
International Search Report for PCT/US2008/0064921 dated Nov. 19, 2008, 8 pages. |
International Search Report for PCT/US2008/075849 dated Mar. 18, 2009, 7 pages. |
Jennings et al., “A new technique in primary tendon repair.” Surg Gynecol Obstet Nov. 1952;95(5):597-600. |
Kaminer, M. et al., “ContourLift™:A New Method of Minimally Invasive Facial Rejuvenation”, Cosmetic Dermatology Jan. 2007; 20(1): 29-35. |
Kelch et al., “Shape-memory Polymer Networks from Olio[(ε-hydroxycaproate)-co-glycolate]dimethacrylates and Butyl Acrylate with Adjustable Hydrolytic Degradation Rate”, Biomacromolecules 2007;8(3):1018-1027. |
Leung, J. et al., “Performance Enhancement of a Knotless Suture via Barb Geometry Modifications”, 7th World Biomaterials Congress 2004, 1 page. |
Leung, J. et al., “Barbed, Bi-directional Medical Sutures: Biomechanical Properties and Wound Closure Efficacy Study”, 2002 Society for Biomaterials 28th Annual Meeting Transactions, 1 page. |
Maitland et al., “Prototype laser-activated shape memory polymer foam device for embolic treatment of aneurysms”, Journal of Biomedical Optics May/Jun. 2007;12(3): pp. 030504-1 to 030504-3. |
Malina, M. et al., “Endovascular AAA Exclusion: Will Stents With Hooks and Barbs Prevent Stent-Graft Migration?”, Journal of Endovascular Surgery 1998; 5; 310-317. |
Mansberger, et al., “A New Type Pull-Out Wire for Tendon Surgery: A Preliminary Report”, Department of Surgery, University Hospital and University of Maryland School of Medicine, Baltimore, Maryland, Received for Publication May 10, 1951, pp. 119-121. |
Mason, M.L., “Primary and secondary tendon suture. A discussion of the significance of technique in tendon surgery.” Surg Gynecol Obstet 70 (1940). |
McKee, G.K., “Metal anastomosis tubes in tendon suture.” The Lancet, May 26, 1945, 659-660. |
McKenzie, A.R.“An Experimental Multiple Barbed Suture for the Long Flexor Tendons of the Palm and Fingers.” J Bone Joint Surg. 49B-(3): 440, Aug. 3, 1967. |
Moran et al., “Bidirectional-Barbed Sutured Knotless Running Anastomosis v Classic van Velthovan in a Model System”, Journal of Endourology Oct. 2007; 21(10); 1175-1177. |
Murtha et al., “Evaluation of a Novel Technique for Wound Closure Using a Barbed Suture”, Journal of the American Society of Plastic Surgeons 2006; 117(6); 1769-1780. |
Paul, Malcolm, “Using Barbed Sutures in Open/Subperiosteal Midface Lifting”, Aesthetic Surgery Journal Nov./Dec. 2006; 26(6):725-732. |
Potenza, Austin, “Tendon Healing Within the Flexor Digital Sheath in the Dog: An Experimental Study”, Journal of Bone & Joint Surgery Jan. 1962; 44A(1):49-64. |
Pulvertaft, “Suture Materials and Tendon Junctures”, American Journal of Surgery Mar. 1965; 109:346-352. |
Rodeheaver, G.T. et al., “Barbed Sutures for Wound Closure: In Vivo Wound Security, Tissue Compatibility and Cosmesis Measurements”, Society for Biomaterials 30th Annual Meeting Transactions, 2 pages. |
Ruff, Gregory, “Technique and Uses for Absorbable Barbed Sutures”, Aesthetic Surgery Journal Sep./Oct. 2006; 26:620-628. |
Singapore Search Report for Singapore Patent Application No. 200702625-5 dated Nov. 26, 2008, 8 pages. |
Singapore Search Report for Singapore Patent Application No. 200702350-0 dated Nov. 26, 2008, 7 pages. |
Singapore Search Report for Singapore Patent Application No. 200703688-2 dated Nov. 26, 2008, 8 pages. |
Sulamanidze, MD, M.A., et al., “Removal of Facial Soft Tissue Ptosis with Special Threads.” Dermatol Surg 2002; 28; pp. 367-371. |
Szarmach, Robin et al., “An Expanded Surgical Suture and Needle Evaulation and Selection Program by a Healthcare Resource Management Group Purchasing Organization”, Journal of Long-Term Effects of Medical Implants 2003; 13(3); 155-170. |
Verdan, Claude, “Primary Repair of Flexor Tendons”, Journal of Bone and Joint Surgery Jun. 1960; 42(4):647-657. |
US 6,447,535, (withdrawn). |
US 6,503,260, (withdrawn). |
Bacci, Pier Antonio, “Chirurgia Estetica Mini Invasiva Con Fili di Sostegno”, Collana di Arti, Pensiero e Scienza; Minelli Editore—2006; 54 pgs. |
Behl, Marc et al., “Shape-Memory Polymers”, Materials Today Apr. 2007; 10(4); 20-28. |
Belkas, J. S. et al., “Peripheral nerve regeneration through a synthetic hydrogel nerve tube”, Restorative Neurology and Neuroscience 23 (2005) 19-29. |
Boenisch, U.W. et al ‘Pull-Out strength and stiffness of meniscal repair using absorbable arrows or Ti-Cron vertical and horizontal loop sutures’ American Journal of Sports Medicine, Sep.-Oct. (1999) vol. 27, Issue 5, pp. 626-631. |
Buckley, P.R. ‘Actuation of Shape Memory Polymer using Magnetic Fields for Applications in Medical Devices’ Master of Science in Mechanical Engineering in Massachusetts Institute of Technology Jun. 2003, 144 pages. |
Buncke, Jr., H.J. et al ‘The Suture Repair of One-Millimeter Vessels, microvascular surgery’ (1966) Report of First Conference; Oct. 6-7 pp. 24-35. |
CCPR Centro de Cirurgia Plastica e Reabilitacao Up Lifting (Aptos Threads) http://ccpr.com.br/upl-l.htm, Aug. 19, 2002 pp. 1-2. |
Dahlin, Lars, “Techniques of Peripheral Nerve Repair”, Scandinavian Journal of Surgery 97: 310-316, 2008. |
Datillo, Jr. P.P. et al ‘Medical Textiles: Application of an Absorbable Barbed Bi-Directional Surgical Suture’ (2002) The Journal of Textile and Apparel Technology and Management vol. 2, Issue 2, pp. 1-5. |
Datillo, Jr., P. et al ‘Tissue holding performance of knotless absorbable sutures’ Society for Biomaterials 29th Annual Meeting Transactions (2003) p. 101. |
Declaration of Dr. Gregory L. Ruff, dated Aug. 19, 2005, 8 pages, with Exhibits A-E. |
De Persia, Raúl et al., “Mechanics of Biomaterials: Sutures After the Surgery”, Applications of Engineering Mechanics in Medicine, GED-University of Puerto Rico, Mayaguez May 2005, p. F1-F27. |
Demyttenaere, Sebastian V. et al., “Barbed Suture for Gastrointestinal Closure: A Randomized Control Trial”, Surgical Innovation; vol. 16, No. 3; Sep. 2009; pp. 237-242. |
Einarsson, Jon I. et al., “Barbed Suture, now in the toolbox of minimally invasive gyn surgery”, OBG Management; vol. 21, No. 9; Sep. 2009; pp. 39-41. |
Gross, Alex, “Physician perspective on thread lifts”, Dermatology Times Feb. 27, 2006(2): 2 pages. |
Ingle, N.P. et al ‘Mechanical Performance and Finite Element Analysis of Bi-directional Barbed Sutures’ Master of Science in Textile Technology & Management at North Carolina State University Aug. 2003, 126 pages. |
Ingle, N.P. et al., “Optimizing the tissue anchoring performance of barbed sutures in skin and tendon tissues”, Journal of Biomechanics 43 (2010); pp. 302-309. |
Khademhosseini, Ali et al., “Nanobiotechnology Drug Delivery and Tissue Engineering”, Chemical Engineering Progress 102:38-42 (2006). |
Kuniholm J.F. et al ‘Automated Knot Tying for Fixation in Minimally Invasive, Robot Assisted Cardiac Surgery’ Master of Science in Mechanical & Aerospace Engineering at North Carolina State University May 2003, 71 pages. |
Lendelin, A. et al ‘Biodegradable, Elastic Shape-Memory Polymers for Potential Biomedical Applications’ (2002) Science vol. 296 pp. 1673-1676. |
Lendelin, A. et al ‘Shape-Memory Polymers’ Agnew Chem Int. Ed. (2002) vol. 41 pp. 2034-2057. |
Leung, J. et al ‘Barbed, Bi-directional Medical Sutures: Biomechanical Properties and Wound Closure Efficacy Study’ 2002 Society for Biomaterials 28th Annual Meeting Transactions 1 page. |
Leung, J. et al ‘Barbed, Bi-directional Surgical Sutures: In Vivo Strength and Histopathology Evaluations’ 2003 Society for Biomaterials 29th Annual Meeting Transactions pp. 100. |
Leung, J. et al., “Barbed Suture Technology: Recent Advances”, Medical Textiles 2004, Advances in Biomedical Textiles and Healthcare Products, Conference Proceedings, IFAI Expo 2004, Oct. 26-27, 2004, Pittsburgh, PA., pp. 62-80. |
Li, Y.Y. et al ‘Polymer Replicas of Photonic Porous Silicon for Sensing and Drug Delivery Applications’ (2003) Science vol. 299 pp. 2045-2047. |
Liu, Changdeng et al., “Shape Memory Polymer with Improved Shape Recovery”, Mater. Res. Soc. Symp. Proc. vol. 855E, 2005 Materials Research Society, pp. W4.7.1-W4.7.6. |
Madduri, Srinivas, et al., “Neurotrophic factors release from nerve conduits for peripheral axonal regeneration”, European Cells and Materials vol. 16; Suppl. 1 (2008), p. 14. |
Mullner, “Metal Foam Has a Good Memory”, Dec. 18, 2007 Original story at <http://www.physorg.com/news117214996.html>. |
Nie, Zhihong and Kumacheva, Eugenia, “Patterning surfaces with functional polymers”, Nature Materials vol. 7(2008): 277-290. |
Paul, Malcolm D. and Rui Avelar, “Quill™ SRS Techniques & Procedures A Novel Approach to Soft Tissue Approximation”, Canada, Angiotech Pharmaceuticals, Inc., First Edition 82007: 20 pages. |
Paul, Malcolm D. and Rui Avelar, “Quill™ SRS Techniques & Procedures A Novel Approach to Soft Tissue Approximation”, Canada, Angiotech Pharmaceuticals, Inc., Fourth Edition 2010, 8 2007-2010: 27 pages. |
Paul, Malcolm D. and Rui Avelar, “Quill™ SRS Techniques & Procedures A Novel Approach to Soft Tissue Approximation”, Canada, Angiotech Pharmaceuticals, Inc., Second Edition 82008: 20 pages. |
Paul, Malcolm D. and Rui Avelar, “Quill™ SRS Techniques & Procedures A Novel Approach to Soft Tissue Approximation”, Canada, Angiotech Pharmaceuticals, Inc., Third Edition 2009, 8 2007-2009: 27 pages. |
Paul, Malcolm D., “Bidirectional Barbed Sutures for Wound Closure: Evoluation and Applications”, Journal of the American College of Certified Wound Specialists (2009) 1, 51-57. |
Quill Medical, Inc. ‘Barbed Sutures, wrinkle filters give patients more innovative, non-surgical options’ Press Release of Program presented at American Society of Plastic Surgeons annual scientific meeting; Philadelphia, Oct. 9, 2004 3 pages. |
Quill Medical, Inc. ‘Quill Medical's Novel-Self-Anchoring Surgical Suture Approved for Sale in Europe’ Press Release; Research Triangle Park, N.C. May 10, 2004, 1 page. |
Quill Medical, Inc., “Quill Medical, Inc. Receives FDA Clearance for First-in-Class Knot-Less Self-Anchoring Surgical Suture”, Press Release; Research Triangle Park, N.C., Nov. 4, 2004, 1 page. |
Richert, Ludovic, et al., “Surface Nanopatterning to Control Cell Growth”, Advanced Materials 2008(15): 1-5. |
Rofin-Baasel ‘Laser Marking on Plastic Materials’ (2001) RB50.0, Rofin-Baasel Inc. 2 pages. |
Scherman, Peter et al., “Sutures as longitudinal guides for the repair of nerve defects-Influence of suture numbers and reconstruction of nerve bifurcations”, Restorative Neurology and Neuroscience 23 79-85. |
Schmid A. et al ‘The outspreading anchor cord. A material for arthroscopic suturing of a fresh anterior cruciate ligament rupture’ Surgical Clinic of the University of Gottingen. |
Semenov, G.M. et al ‘Surgical Suture’ (2001) Piter, Saint Petersburg, pp. 12-13 and 92-98. |
Serafetinides, AA ‘Short pulse laser beam interactions with polymers biocompatible materials and tissue’ Proce SPIE vol. 3052 (1996) pp. 111-123. |
Sulamanidze, M. et al., “APTOS Suture Lifting Methods: 10 Years of Experience”, Clin Plastic Surg 36 (2009); pp. 281-306. |
Sulamanidze, M.A. et al ‘Clinical aspects of bloodless facelift using APTOS filaments’ A.V. Vishnevsky Institute of Surgery, Bol=shaya Serpukhovskaya ul, 7, 113811, Moscow, Russia (2002) pp. 24-34. |
Sulamanidze, M.A. et al ‘Facial lifing with APTOS threads’ International Journal of Cosmetic Surgery and Aesthetic Dermatology (2001) No. 4 pp. 1-8. |
Sulamanidze, M.A. et al ‘Facial lifing with “Aptos” threads’ http://fonendo.com (Jul. 18, 2001) pp. 1-4. |
Sulamanidze, M.A. et al ‘Management of Facial Rhytids by Subcutaneous Soft Tissue Dissection’ (2000) International Journal of Cosmetic Surgery and Aesthetic Dermatology vol. 2 No. 4 pp. 255-259. |
Sulamanidze, M.A. et al ‘Morphological foundations of facelift using APTOS filaments’ Bolshaya Serpukhovskaya ul 27, 113811 Moscow, Russia (2002) pp. 1926. |
Sulamanidze, MD, M.A., et al., “Soft tissue lifting in the mid-face: old philosophy, new approach-internal stitching technique (APTOS Needle)”, Plastic and Aesthetic Surgery Clinic TOTAL SHARM, Moscow, Russia, (2005):15-29. |
Sulzle, Inc. B.G. et al Drilled End Surgical Needles Jul. 2002 Syracuse, New York. |
Surgical Specialties Corporation, “Wound Closure Catalog”; Summer 2005, 5 pages. |
Tan E.L. et al., “A wireless, passive strain sensor based on the harmonic response of magnetically soft materials”, Smart Materials and Structures 17 (2008): pp. 1-6. |
Up Lifting (Aptos Threads), http://www.ccpr.com.br/upl-l.htm Aug. 19, 2002 pp. 1-2. |
Villa, Mark T. et al., “Barbed Sutures: A Review of Literature”, Plastic and Reconstructive Surgery; Mar. 2008; vol. 121, No. 3; pp. 102e-108e. |
Wu. W. ‘Barbed Sutures in Facial Rejuvenation’ Aesthetic Surgery Journal (2004) vol. 24 pp. 582-587. |
Zoltan, J. ‘Cicatrix Optimia: Techniques for Ideal Wound Healing’ English language edition University Park Press Baltimore (1977) Chapter 3 pp. 54-55. |
Communication from EPO re: 10000486 dated Apr. 4, 2011. |
European Search Report re: EP05025816 dated Jun. 23, 2006. |
European Search Report for EP07006258.3 dated May 4, 2007, 4 pages. |
European Search Report for EP07015906 dated Oct. 2, 2007. |
European Search Report for EP07015905.8 dated Oct. 23, 2007, 2 pages. |
European Search Report for EP07016222 dated Jan. 7, 2008. |
European Search Report for EP10000629.5 dated Mar. 10, 2010, 4 pages. |
European Search Report re: EP10000486 dated Apr. 23, 2010. |
European Search Report for EP10011871.0 dated Dec. 3, 2010, 2 pages. |
European Search Report for EP10011868.6 dated Dec. 6, 2010, 2 pages. |
European Search Report for EP10011869 dated Jan. 20, 2011. |
European Search Report for EP10186592.1 dated Jan. 19, 2011, 2 pages. |
Extended European Search Report re: 07015905.8 dated Oct. 2, 2007. |
Extended European Search Report re: 07016222.7 dated Jan. 30, 2008. |
International Preliminary Examination Report re: PCT/US1998/10478 dated Dec. 11, 1999. |
International Preliminary Report re: PCT/US2009/040545 dated Oct. 19, 2010. |
International Search Report for PCT/US1998/10478 dated Sep. 23, 1998. |
International Search Report for PCT/US2002/027525 dated Dec. 9, 2002, 3 pages. |
International Search Report for PCT/2003/30666 dated Dec. 15, 2004. |
International Search Report for PCT/US2003/25088 dated Dec. 29, 2003. |
International Search Report for PCT/US2009/040545 dated Oct. 29, 2009. |
Partial European Search Report re: EP05025816 dated Mar. 20, 2006. |
Supplementary European Search Report re: EP98923664 dated Jun. 12, 2001. |
Supplementary European Search Report re: EP03785177 dated May 19, 2009. |
U.S. Appl. No. 08/859,887, filed May 21, 1997. |
U.S. Appl. No. 09/896,455, filed Jun. 29, 2001. |
U.S. Appl. No. 09/919,750, filed Jul. 31, 2001. |
U.S. Appl. No. 09/943,733, filed Aug. 31, 2001. |
U.S. Appl. No. 10/216,516, filed Aug. 9, 2002. |
U.S. Appl. No. 10/065,280, filed Sep. 30, 2002. |
U.S. Appl. No. 10/065,279, filed Sep. 30, 2002. |
U.S. Appl. No. 10/065,278, filed Sep. 30, 2002. |
U.S. Appl. No. 10/914,755, filed Aug. 9, 2004. |
U.S. Appl. No. 10/941,347, filed Sep. 15, 2004. |
U.S. Appl. No. 11/154,230, filed Jun. 16, 2005. |
U.S. Appl. No. 11/154,863, filed Jun. 16, 2005. |
U.S. Appl. No. 11/307,901, filed Feb. 27, 2006. |
U.S. Appl. No. 11/307,900, filed Feb. 27, 2006. |
U.S. Appl. No. 11/440,621, filed May 25, 2006. |
U.S. Appl. No. 11/440,631, filed May 25, 2006. |
U.S. Appl. No. 11/968,494, filed Jan. 2, 2008. |
U.S. Appl. No. 11/968,496, filed Jan. 2, 2008. |
U.S. Appl. No. 12/119,749, filed May 13, 2008. |
U.S. Appl. No. 12/340,530, filed Dec. 19, 2008. |
U.S. Appl. No. 12/495,497, filed Jun. 30, 2009. |
U.S. Appl. No. 61/357,018, filed Jun. 21, 2010. |
U.S. Appl. No. 12/849,960, filed Aug. 4, 2010. |
U.S. Appl. No. 12/849,969, filed Aug. 4, 2010. |
U.S. Appl. No. 12/849,977, filed Aug. 4, 2010. |
U.S. Appl. No. 12/849,983, filed Aug. 4, 2010. |
U.S. Appl. No. 12/849,991, filed Aug. 4, 2010. |
U.S. Appl. No. 12/850,035, filed Aug. 4, 2010. |
U.S. Appl. No. 12/850,063, filed Aug. 4, 2010. |
U.S. Appl. No. 13/164,438, filed Jun. 20, 2011. |
U.S. Appl. No. 13/335,220, filed Dec. 22, 2011. |
Madhave et al ‘A biodegradable and biocompatible gecko-inspired tissue adhesive’ PNAS 105(7) pp. 2307-2312 (2008). |
Middleton and Tipton ‘Synthetic Biodegradable Polymers as Medical Devices’ (1998) Medical Plastics and Biomaterials Magazine, 9 pages. |
International Search Report for PCT/US2003/30664 dated May 25, 2004. |
U.S. Appl. No. 61/290,750, filed Dec. 29, 2009. |
U.S. Appl. No. 61/296,721, filed Jan. 20, 2010. |
U.S. Appl. No. 10/065,256, filed Sep. 30, 2002. |
U.S. Appl. No. 11/691,845, filed Mar. 27, 2007. |
U.S. Appl. No. 11/747,085, filed May 10, 2007. |
U.S. Appl. No. 12/101,885, filed Apr. 11, 2008. |
U.S. Appl. No. 12/340,444, filed Dec. 19, 2008. |
U.S. Appl. No. 12/392,939, filed Feb. 25, 2009. |
U.S. Appl. No. 12/849,884, filed Aug. 4, 2010. |
U.S. Appl. No. 12/849,895, filed Aug. 4, 2010. |
U.S. Appl. No. 12/849,901, filed Aug. 4, 2010. |
U.S. Appl. No. 12/849,946, filed Aug. 4, 2010. |
U.S. Appl. No. 12/850,397, filed Aug. 4, 2010. |
U.S. Appl. No. 12/850,408, filed Aug. 4, 2010. |
U.S. Appl. No. 12/850,433, filed Aug. 4, 2010. |
U.S. Appl. No. 12/850,447, filed Aug. 4, 2010. |
U.S. Appl. No. 12/850,455, filed Aug. 4, 2010. |
U.S. Appl. No. 12/850,467, filed Aug. 4, 2010. |
U.S. Appl. No. 12/850,480, filed Aug. 4, 2010. |
U.S. Appl. No. 12/850,498, filed Aug. 4, 2010. |
U.S. Appl. No. 12/972,802, filed Dec. 20, 2010. |
Gross, R.A. et al ‘Biodegradable Polymers for the Environment’ Science (2002) vol. 297, Issue 5582 pp. 803. |
Jeong, H.E. et al ‘A nontransferring dry adhesive with hierarchial polymer nanohairs’ PNAS 106 (14) pp. 5639-5644 (2009). |
Martin, D.P. et al ‘Medical applications of poly-4-hydroxybutyrate: a strong flexible absorbable biomaterial’ Biochemical Engineering Journal vol. 16 (2003) pp. 97-105. |
European Search Report for EP09014651 dated Jan. 12, 2010. |
European Search Report re: 10004453 dated Jun. 15, 2010. |
European Search Report for EP10011872 dated Apr. 20, 2011. |
European Search Report for EP10012437 dated Apr. 28, 2011. |
European Search Report for EP10184766 dated Apr. 20, 2011. |
International Preliminary Report re: PCT/US2007/002688 dated Aug. 14, 2008. |
International Preliminary Report re: PCT/US2008/060127 dated Oct. 13, 2009. |
International Preliminary Report re: PCT/US2008/087788 dated Jun. 22, 2010. |
International Preliminary Report re: PCT/US2009/032693 dated Aug. 3, 2010. |
International Preliminary Report re: PCT/US2009/041685 dated Oct. 26, 2010. |
International Preliminary Report re: PCT/US2009/044274 dated Nov. 17, 2010. |
International Preliminary Report re: PCT/US2011/035431 dated Nov. 6, 2012. |
International Preliminary Report re: PCT/US2011/059238 dated May 7, 2013. |
International Search Report for PCT/US1994/09631 dated Dec. 9, 1994. |
International Search Report for PCT/US2002/20449 dated May 20, 2003. |
International Search Report for PCT/US2003/030424 dated Nov. 1, 2004. |
International Search Report for PCT/US2003/030664 dated May 25, 2004. |
International Search Report re: PCT/US2003/030674 dated Sep. 2, 2004. |
International Search Report re: PCT/US2004/014962 dated Feb. 24, 2005. |
International Search Report for PCT/US2005/017028 dated Mar. 26, 2008. |
International Search Report for PCT/US2007/002688 dated Oct. 22, 2007. |
International Search Report for PCT/US2008/077813 dated Mar. 31, 2009. |
International Search Report for PCT/US2008/082009 dated Feb. 16, 2010. |
International Search Report for PCT/US2009/032693 dated Aug. 26, 2009. |
International Search Report for PCT/US2009/034703 dated Sep. 28, 2009. |
International Search Report for PCT/US2009/063081 dated Aug. 2, 2010. |
International Search Report for PCT/US2009/041685 dated Dec. 22, 2009. |
International Search Report for PCT/US2009/044274 dated Jan. 15, 2010. |
International Search Report for PCT/US2010/056898 dated Aug. 2, 2011. |
International Search Report for PCT/US2010/060889 dated Oct. 11, 2011. |
International Search Report for PCT/US2011/034660 dated Feb. 8, 2012. |
International Search Report for PCT/US2011/035270 dated Jan. 12, 2012. |
International Search Report for PCT/US2011/035271 dated Jan. 12, 2012. |
International Search Report re: PCT/US2011/035431 dated Jan. 12, 2012. |
International Search Report re: PCT/US2011/040014 dated Feb. 9, 2012. |
International Search Report for PCT/US2011/059238 dated May 21, 2012. |
International Search Report for PCT/US2011/060069 dated May 18, 2012. |
International Search Report for PCT/US2012/030441 dated Sep. 27, 2012. |
International Search Report for PCT/US2012/041001 dated Sep. 26, 2012. |
Singapore Search Report for Singapore Patent Application No. 201103117-6 dated Mar. 8, 2013. |
Supplementary European Search Report re: EP03752630 dated Nov. 17, 2005. |
Supplementary European Search Report re: 03770556 dated Nov. 17, 2005. |
Supplementary European Search Report re: 03754965 dated Nov. 18, 2005. |
Supplementary European Search Report re: 05750101 dated Apr. 7, 2010. |
Supplementary European Search Report re: 07017663 dated Nov. 7, 2007. |
Written Opinion of the International Searching Authority re: PCT/US2010/056898 dated Jul. 29, 2011. |
Written Opinion of the International Searching Authority re: PCT/US2012/041001 dated Aug. 27, 2012. |
Blaker, J.J. et al ‘Development and Characterisation of silver-doped bioactive glass-coated sutures for tissue engineering and wound healing applications’ Biomaterials (2004) vol. 25, No. 7-8 pp. 1319-1329. |
Number | Date | Country | |
---|---|---|---|
20090012560 A1 | Jan 2009 | US |
Number | Date | Country | |
---|---|---|---|
60911814 | Apr 2007 | US |